selenium has been researched along with Cancer of Prostate in 333 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (1.50) | 18.7374 |
| 1990's | 16 (4.80) | 18.2507 |
| 2000's | 181 (54.35) | 29.6817 |
| 2010's | 118 (35.44) | 24.3611 |
| 2020's | 13 (3.90) | 2.80 |
| Authors | Studies |
|---|---|
| Booth, DE; Cooper, ML; Gopalakrishna-Remani, V; Green, FR; Rayman, MP | 1 |
| Bright, R; Girija, AR; Kodama, T; Lebepe, TC; Maluleke, R; Ncapayi, V; Ninan, N; Oluwafemi, OS; Parani, S; Tsolekile, N; Vasilev, K | 1 |
| Beretta, GL; Zaffaroni, N | 1 |
| Feng, X; Gao, X; Hu, B; Niu, T; Tang, B; Xia, Q; Xu, K; Yang, J; Zhao, Z | 1 |
| Bosland, MC; Deng, Y; Lü, J; Schlicht, MJ | 1 |
| Goodman, PJ; Lucia, MS; Neuhouser, ML; Schenk, JM; Tangen, CM; Thompson, IM; Till, C | 1 |
| Bera, S; Diamond, AM | 1 |
| Chia, SE; Geok, PP; Lee, J; Lim, JT; Ong, CN; Seow, WJ; Tan, YQ; Valeri, L | 1 |
| Bielecki, W; Bobrowska Korczak, B; Domanska, K; Jelińska, M; Skrajnowska, D; Wrzosek, M; Zawistowska, M | 1 |
| Barbanente, A; Esposti, LD; Iafisco, M; Leeuwenburgh, SCG; Margiotta, N; Nadar, RA; Palazzo, B; van den Beucken, JJJP | 1 |
| Liao, G; Liu, Y; Tang, J; Wang, D; Xiong, H; Zhang, Q; Zuo, H | 1 |
| Frederiksen, K; Hughes, DJ; Jenab, M; Morris, S; Olsen, A; Outzen, M; Overvad, K; Schomburg, L; Tjønneland, A | 1 |
| Augustin, M; Chandrasekar, T; Heinzer, H; Knipper, S; Kuehl, L; Tennstedt, P; Thederan, I; Tilki, D; Zyriax, BC | 1 |
| Chen, C; Li, Y; Liao, G; Ma, H; Sheng, Y | 1 |
| Cameotra, SS; Sonkusre, P | 1 |
| Chen, WJ; Hsueh, YM; Huang, CY; Lin, YC; Pu, YS; Shiue, HS; Su, CT; Tsai, CS | 1 |
| Arnone, S; Blefari, F; Carini, M; Gentile, M; Giannantoni, A; Iapicca, G; Morgia, G; Palmieri, F; Pareo, RM; Russo, GI; Santelli, G; Vespasiani, G; Voce, S | 1 |
| Chiang, EC; Waters, DJ | 1 |
| Ansong, E; Deaton, R; Diamond, AM; Ekoue, DN; Freeman, VL; Gann, PH; Kajdacsy-Balla, A; Lacher, C; Liu, L; Macias, V; Nonn, L; Picklo, M; Prins, GS | 1 |
| Bonilla, C; Davey Smith, G; Evans, DM; Haycock, PC; Langdon, RJQ; Langenberg, C; Lewis, SJ; Lotta, LA; Martin, RM; Relton, CL; Yarmolinsky, J | 1 |
| Azami, M; Mohammadi, Y; Sayehmiri, K; Soleymani, A; Tardeh, Z | 1 |
| Gao, MX; Huang, CZ; Li, YF; Yang, L; Zou, HY | 1 |
| Chen, T; Lai, H; Liu, C; Wang, X; Zeng, D; Zhang, Q | 1 |
| Algotar, AM; Hsu, CH; Singh, P; Stratton, SP | 1 |
| Dunn, BK; Nicastro, HL | 1 |
| Nambiar, D; Singh, RP | 1 |
| Azzouzi, AR; Cancel-Tassin, G; Cussenot, O; Eisinger, F; Gravis, G; Rossi, D | 1 |
| Pascal, M; Wu, XH; Yang, L | 1 |
| Andriole, GL; Nepple, KG; Sandhu, GS; Tanagho, YS | 1 |
| Brasky, TM; Darke, AK; Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Meyskens, FL; Minasian, LM; Parnes, HL; Song, X; Tangen, CM; Thompson, IM | 1 |
| Geybels, MS; Goldbohm, RA; van den Brandt, PA; van Schooten, FJ; Verhage, BA | 1 |
| Chun, OK; Fontham, ET; Koo, SI; Su, J; Vance, TM | 1 |
| Hadjipavlou, M; Khan, S; Philippou, Y; Rane, A | 1 |
| Andriole, GL; Freedland, SJ; Hamilton, RJ; Vemana, G | 1 |
| Cabang, AB; Thompson, IM; Wargovich, MJ | 1 |
| Geybels, MS; Green, FR; Rayman, MP; Schouten, LJ; van Breda, SG; van den Brandt, PA; van Schooten, FJ; Verhage, BA | 1 |
| Darke, AK; Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Lippman, SM; Meyskens, FL; Minasian, LM; Morris, JS; Parnes, HL; Tangen, CM; Thompson, IM | 1 |
| Frankel, PH; Madsen, FC; Parker, RS; Whanger, PD | 1 |
| Payton, S | 1 |
| Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Meyskens, FL; Minasian, LM; Neuhauser, ML; Parnes, HL; Schenk, JM; Song, X; Tangen, CM; Thompson, IM; Till, C | 1 |
| Kristal, A; Platz, EA; Thompson, I | 1 |
| Heinzl, S | 1 |
| Albanes, D; Brown, PH; Fleshner, NE; Gaziano, JM; Goodman, PJ; Klein, EA; Meyskens, FL; Mondul, AM; Parnes, HL; Song, X; Taylor, PR; Thompson, IM; Till, C; Weinstein, SJ | 1 |
| Algotar, AM; Behnejad, R; Stratton, MS; Stratton, SP | 1 |
| Schwartz, GG | 1 |
| Bauer, SR; Carroll, PR; Chan, JM; Gerstenberger, JP; Song, X; Sosa, E; Van Blarigan, EL; Witte, JS | 1 |
| Kormos, W | 1 |
| Dueregger, A; Eder, IE; Heidegger, I; Klocker, H; Ofer, P; Perktold, B; Ramoner, R | 1 |
| Chan, JM; DuPre, N; Kenfield, SA; L Giovannucci, E; Stampfer, MJ; Van Blarigan, EL | 1 |
| Brasky, TM; Kristal, AR | 1 |
| Anuszewska, E; Flis, A; Hoser, G; Jastrzębski, Z; Królikowska, MA; Książek, I; Remiszewska, M; Sitarz, K; Śliwka, L; Sochacka, M; Suchocka, Z; Suchocki, P; Wroczyński, P | 1 |
| Dunn, BK; Ghosh, S; Kramer, BS | 1 |
| Ramamoorthy, V; Rubens, M; Saxena, A; Shehadeh, N | 1 |
| Baratta, F; Brusa, P; Cattel, L; Chiorino, G; Daniele, L; Frea, B; Gontero, P; Gregnanin, I; Marra, G; Oderda, M; Soria, F; Zitella, A | 1 |
| Ataman, OY; Bakırdere, S; Çelen, İ; Korkmaz, M; Lekili, M; Müezzinoğlu, T; Neşe, N; Şenol, F | 1 |
| Thoma, C | 1 |
| Arnold, KB; Barrington, WE; Etzioni, R; Kristal, AR; Lucia, MS; Neuhouser, ML; Schenk, JM; Thompson, IM | 1 |
| Citronberg, J; Fedirko, V; Goodman, M; Hartman, T; Kim, Y; Wei, J | 1 |
| Christensen, MJ; Hopkins, TJ; Lephart, ED; Nakken, HL; Shaw, B; Urie, PM | 1 |
| Chan, J; Kantoff, PW; Lee, GS; Mucci, LA; Penney, KL; Sun, T; Xie, W; Yang, M | 1 |
| Auvinen, A; Määttänen, L; Murtola, TJ; Sarre, S; Tammela, TL | 1 |
| Christensen, J; Friis, S; Larsen, EH; Larsen, SB; Olsen, A; Outzen, M; Overvad, K; Tjønneland, A | 1 |
| Bosland, MC | 1 |
| Aebischer, B; Akboga, MK; Akdamar, G; Alcalay, RN; Álvarez-Pérez, S; Aydogdu, S; Balci, KG; Barcaro, G; Bišová, K; Blanco, JL; Brewer, SH; Caruthers, SD; Ceylan, O; Chadwick, JA; Chang, DD; Che, JM; Chen, QQ; Chen, W; Chen, Z; Chung, M; Chung, W; Colecraft, HM; Coteli, E; Dogan, H; Dong, S; Elsig, S; Fahn, S; Fang, XJ; Feng, MG; Fenlon, EE; Floyd, KT; Fokdal, L; Ford, B; Fortunelli, A; Freudenberg, R; Gan-Or, Z; García, ME; Gillham, C; Giovannelli, D; Goertz, RS; Gulati, V; Haie-Meder, C; Hao, YY; Hatano, K; Hines, KJ; Hines, SM; Hirakawa, H; Hoskin, P; Hu, JH; Huang, P; Huang, Y; Hubicka, U; Inoue, Y; Ishii, N; Janssen, PM; Jin, Z; Johnson, A; Jürgenliemk-Schultz, I; Kaineder, K; Kamei, K; Kang, U; Karatas, F; Kash, TL; Katayama, Y; Keupp, J; Kirisits, C; Kisacik, H; Kodama, K; Kotzerke, J; Kryczyk, A; Kuhness, D; Kuo, S; Lanza, GM; Le Bris, N; Levin, DE; Levy, OA; Li, B; Li, H; Li, X; Liang, GD; Liang, Y; Liao, RQ; Lin, JT; Lindegaard, JC; Liong, C; Liu, B; Liu, C; Liu, GH; Liu, L; Liu, Q; Liu, X; Lowe, J; Lowery-Gionta, EG; Ma, YH; Maden, O; Mankad, V; Marder, KS; Marshall, SA; Martínez-Nevado, E; Maucksch, U; Mazeron, R; Mazzone, CM; Mazzoni, P; Mezricky, D; Mizokami, Y; Naumann, A; Navarro, M; Netzer, FP; Neurath, MF; Nie, Q; Oliva, P; Ozeke, O; Peláez, T; Pfeifer, L; Pleil, KE; Pomp, S; Pötter, R; Puckerin, AA; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Řezanka, M; Řezanka, T; Rinker, JA; Rouleau, GA; Runge, R; Sahin, MD; Sakai, A; Schmieder, AH; Schmitz, AJ; Schultz, EJ; Šegedin, B; Sementa, L; Shen, Y; Shiotsuki, I; Shirahama, M; Staley, J; Starovoytov, V; Sterrer, M; Strobel, D; Sturdza, A; Subramanyam, P; Surnev, S; Swager, SA; Taeymans, J; Tan, H; Tan, LT; Tanderup, K; Temizhan, A; Terao, T; Thiele, TE; Tran, T; Tucker, MJ; Vetriani, C; Vítová, M; Wang, JP; Wang, L; Wang, M; Wang, X; Waters, CH; Weng, SX; Wickline, SA; Wildner, D; Wodarcyk, AJ; Wolf, P; Wu, L; Wu, YL; Wunderlich, G; Xiong, L; Xu, P; Yang, GS; Yang, XN; Yang, Y; Yayla, C; Ying, SH; Zachleder, V; Zhang, XG; Zhang, XK; Zhang, Y; Zheng, JY; Zhong, WZ; Zhu, J; Zhu, YJ; Żmudzki, P | 1 |
| Chan, JM; Darke, AK; Goodman, PJ; Kantoff, PW; Klein, EA; Lee, GM; Mucci, LA; Peisch, S; Penney, KL; Rae, JM; Sun, T; Tangen, CM; Thompson, IM; Tinianow, AM | 1 |
| Albanes, D; Allen, NE; Appleby, PN; Barnett, MJ; Black, A; Bueno-de-Mesquita, HB; Deschasaux, M; Galan, P; Goodman, GE; Goodman, PJ; Gunter, MJ; Heliövaara, M; Helzlsouer, KJ; Henderson, BE; Hercberg, S; Key, TJ; Knekt, P; Kolonel, LN; Lasheras, C; Linseisen, J; Metter, EJ; Neuhouser, ML; Olsen, A; Pala, V; Platz, EA; Reid, ME; Rissanen, H; Schenk, JM; Stampfer, MJ; Stattin, P; Tangen, CM; Touvier, M; Travis, RC; Trichopoulou, A; van den Brandt, PA | 1 |
| Axcrona, K; Bjøro, T; Blomhoff, R; Bolstad, N; Brennhovd, B; Bøhn, SK; Carlsen, MH; Eri, LM; Fosså, SD; Hulander, E; Karlsen, AS; Klein, W; Laake, P; Lilleby, W; Paur, I; Smeland, SS; Svindland, A; Taskén, KA; Vlatkovic, L | 1 |
| Anderson, K; Arnold, KB; Caban-Holt, A; Cassano, PA; Christen, WG; Crowley, JJ; Darke, AK; Goodman, PJ; Hartline, J; Klein, EA; Lance, P; Meyskens, FL; Minasian, LM; Tangen, CM; Yee, M | 1 |
| Cui, Z; Liu, C; Liu, D; Liu, G | 1 |
| Ahmad, N; Ahsan, H; Mukhtar, H; Nihal, M; Reagan-Shaw, S | 1 |
| Magri, V; Marras, E; Perletti, G; Trinchieri, A | 1 |
| Gao, AC; Nadiminty, N | 1 |
| Peters, U; Takata, Y | 1 |
| Buentzel, J; Giedl, J; Kisters, K; Klotz, T; Kundt, G; Micke, O; Muecke, R; Prott, FJ | 1 |
| Chhabra, D; Gopalakrishna, R; Gundimeda, U; Schiffman, JE; Wong, J; Wu, A | 1 |
| Hodge, A; Itsiopoulos, C; Kaimakamis, M | 1 |
| Agudo, A; Allen, NE; Appleby, PN; Barricarte, A; Bingham, S; Boeing, H; Boffetta, P; Bueno-de-Mesquita, HB; Grioni, S; Hallmans, G; Johnsen, NF; Kaaks, R; Key, TJ; Khaw, KT; Kiemeney, LA; Larrañaga, N; Linseisen, J; Misirli, G; Overvad, K; Palli, D; Riboli, E; Rinaldi, S; Roddam, AW; Rodriguez, L; Sacerdote, C; Sánchez, MJ; Slimani, N; Stattin, P; Tjønneland, A; Tormo, MJ; Trichopoulos, D; Trichopoulou, A; Tumino, R; Weikert, S | 1 |
| Gann, PH | 1 |
| Albanes, D; Arnold, KB; Baker, LH; Bearden, JD; Claudio, J; Coltman, CA; Cook, ED; Crawford, ED; Crowley, JJ; Darke, AK; Ford, LG; Ganz, PA; Gaziano, JM; Goodman, GE; Goodman, PJ; Hartline, JA; Jagpal, TJ; Karp, DD; Klein, EA; Kristal, AR; Lieber, MM; Lippman, SM; Lucia, MS; Meyskens, FL; Minasian, LM; Parnes, HL; Parsons, JK; Probstfield, JL; Santella, RM; Taylor, PR; Thompson, IM; Walther, P; Winquist, E | 1 |
| Adami, HO; Cooper, ML; Green, FR; Grönberg, H; Rayman, MP; Wiklund, F | 1 |
| Albanes, D | 2 |
| Fairweather-Tait, S; Hurst, R | 2 |
| Bekaert, B; Rayman, MP | 1 |
| Cooney, RV; Franke, AA; Gill, JK; Goodman, MT; Henderson, BE; Kolonel, LN; Le Marchand, L; Steven Morris, J; Wilkens, LR | 1 |
| Dunn, BK; Ford, LG; Ryan, A | 1 |
| Bosland, MC; Kandaş, NO; Randolph, C | 1 |
| Hu, H; Jiang, C; Jiang, W; Lü, J; Pei, H; Wang, L; Zhang, J | 1 |
| Gladyshev, VN; Hatfield, DL | 1 |
| Fitzpatrick, JM; Schröder, FH; Schulman, C; Zlotta, AR | 1 |
| Simon, HB | 1 |
| El-Bayoumy, K; Facompre, N | 1 |
| Allen, NE; Key, TJ | 1 |
| Block, KI | 1 |
| Amling, CL; Colli, JL | 1 |
| Chen, HR; Shen, L; Sheng, JP | 1 |
| Alkan, Z; Dawson, K; Hawkes, WC; Richter, BD; Wang, TT | 1 |
| Fleshner, NE; Jacob, LE; Klotz, LH; Nam, RK; Ramani, M; Sugar, LM; Venkateswaran, V | 1 |
| Combs, GF; Rayman, MP; Waters, DJ | 1 |
| Pinsky, PF | 1 |
| Hawk, ET; Lippman, SM | 1 |
| Schrauzer, GN | 1 |
| Lippman, SM; Platz, EA | 1 |
| Abe, M; Chan, JM; Kantoff, PW; King, IB; Oh, WK; Regan, MM; Stampfer, MJ; Xie, W | 2 |
| Bisson, WH; Cooper, AJ; Dai, J; Dashwood, RH; Lee, JI; Nian, H; Pinto, JT; Sinha, R | 1 |
| King, IB; Kristal, AR; Lin, DW; Morris, JS; Peters, U; Takata, Y | 1 |
| Darago, A; Kilanowicz, A; Sapota, A; Taczalski, J | 1 |
| Buntinx, F; Goossens, ME; Zeegers, MP | 1 |
| Amin, S; Desai, D; King, T; Null, K; Sinha, I; Sinha, R; Suckow, MA; Wolter, W | 1 |
| Abdulah, R; Faried, A; Ito, K; Kobayashi, K; Koyama, H; Kuwano, H; Murakami, M; Suradji, EW; Suzuki, K; Yamazaki, C | 1 |
| Bristow, RG; Tabassum, A; Venkateswaran, V | 1 |
| Sakai, H | 1 |
| Byrne, DJ | 1 |
| Anderson, KB; Arnold, KB; Campbell, RD; Cook, ED; Hamilton, SJ; Hermos, JA; McCaskill-Stevens, W; Minasian, LM; Moody-Thomas, S; Probstfield, JL | 1 |
| Drasch, G; Schöpfer, J; Schrauzer, GN | 2 |
| Altwein, JE | 1 |
| Hunter, DJ; Kantoff, PW; Kraft, P; Kurth, T; Li, H; Ma, J; Morris, JS; Mucci, LA; Penney, KL; Schumacher, FR; Stampfer, MJ | 1 |
| Gröber, U | 1 |
| Canene-Adams, K; Diamond, AM; Erdman, JW; Ford, NA; Lindshield, BL; Wallig, MA | 1 |
| Cervi, D; Fleshner, NE; Klotz, LH; Nam, RK; Pak, B; Sugar, LM; Venier, NA; Venkateswaran, V | 1 |
| López Fontana, CM; López Laur, JD; Pérez Elizalde, RF; Recalde, GM; Uvilla, AL; Vanrell, MC | 1 |
| Haces, A; Hormann, V; Johnson, M; Kumi-Diaka, J; Merchant, K | 1 |
| El-Bayoumy, K; Facompre, N; Richie, JP; Russell, S; Sinha, I; Sinha, R; Somiari, RI | 1 |
| Ahmann, FR; Algotar, AM; Clark, LC; Hsu, CH; Ranger-Moore, J; Slate, EH; Stratton, MS; Stratton, SP; Thompson, PA | 1 |
| Cao, N; Guan, QL; Jiang, L; Ma, B; Mi, DH; Tian, JH; Wu, J; Yang, KH; Yang, SH; Yao, N | 1 |
| Ahmann, FR; Algotar, AM; Hsu, CH; Stratton, MS; Stratton, SP | 1 |
| Briollais, L; Choi, YH; Fleshner, N; Ibrahim-zada, I; Jarjanazi, H; Musquera, M; Ozcelik, H; Savas, S; Venkateswaran, V | 1 |
| Chaisanguanthum, RM; Chlebowski, RT; Jackson, DM; Menon, R | 1 |
| Akesson, B; Endermann, T; Hesketh, J; Jansen, E; Linseisen, J; Méplan, C; Rohrmann, S; Schomburg, L; Steinbrecher, A | 1 |
| Calvo, A; Nguewa, PA | 1 |
| Ahmann, FR; Algotar, AM; Clark, LC; Dalkin, BL; Hsu, CH; Nagle, RB; Stratton, MS; Stratton, SP; Xu, MJ | 1 |
| Beam, C; Centeno, JA; Gao, W; Gray, MA; Kajdacsy-Balla, AA; Liang, WM; Macias, V; Sarafanov, AG; Todorov, TI | 1 |
| Godwin, M; Stratton, J | 1 |
| DiSilvestro, RA; Hitchcock, C; Joseph, E; Zhang, W | 1 |
| Ercole, B; Parekh, DJ | 1 |
| King, T; Null, K; Pinto, JT; Sinha, I; Sinha, R; Suckow, MA; Wolter, W | 1 |
| Chin, J; Donnelly, B; Farley, A; Fleshner, NE; Gleave, M; Hersey, K; Jansz, K; Kapusta, L; Lacombe, L; Parulekar, WR; Siemens, DR; Tanguay, S; Trpkov, K; Tu, D | 1 |
| Abdulah, R; Kobayashi, K; Koyama, H; Yamazaki, C | 1 |
| Bi, X; Gao, X; Guo, Q; Kong, L; Li, Y; Wang, Q; Yuan, Q; Zhu, H | 1 |
| Aksu, A; Alici, B; Ataus, S; Aydemir, B; Durak, H; Guzel, S; Kiziler, L | 1 |
| Alberts, DS; Berry, DL; Crawford, ED; Davis, W; Ely, B; Gaziano, JM; Jarrard, DF; Klein, EA; Lee, WR; Lippman, SM; Marshall, JR; Minasian, LM; Parnes, HL; Ray, M; Sakr, WA; Tangen, CM; Thompson, IM; Wood, DP | 1 |
| Garmo, H; Grundmark, B; Holmberg, L; Zethelius, B | 1 |
| Baker, LH; Chin, JL; Crowley, JJ; Darke, AK; Ford, LG; Gaziano, JM; Goodman, GE; Goodman, PJ; Karp, DD; Klein, EA; Klotz, L; Lieber, MM; Lippman, SM; Lucia, MS; Meyskens, FL; Minasian, LM; Parnes, HL; Parsons, JK; Tangen, CM; Thompson, IM; Walther, PJ | 1 |
| Cheng, WH; Holmstrom, A; Li, X; Wu, RT; Xiao, Z; Zeng, H | 1 |
| Das, A; El-Bayoumy, K; Jordan, R; Loughran, TP; Renganathan, K; Russell, S; Somiari, R; Wolfe, S | 1 |
| McNeil, C | 1 |
| Díaz, Mdel P; Eynard, AR; La Vecchia, C; Niclis, C; Román, MD | 1 |
| Cheng, WH; Holmstrom, A; Lei, KY; Wu, RT; Zeng, H | 1 |
| Moyad, MA | 3 |
| Klein, EA; Thompson, IM | 2 |
| Gaby, AR | 1 |
| Fried, ED; Hoskote, SS; Nadkarni, GN | 1 |
| Zermann, DH | 1 |
| Avery, KN; Davis, M; Donovan, J; Gilbert, R; Gunnell, D; Hamdy, FC; Holly, JM; Lane, JA; Martin, RM; Metcalfe, C; Neal, DE; Rowlands, MA; Young, NJ | 1 |
| Bubley, G; Klempner, SJ | 1 |
| Chan, JM; Richman, EL | 1 |
| Aune, D; Beynon, R; Collings, R; Fairweather-Tait, SJ; Greenwood, DC; Harvey, LJ; Hooper, L; Hurst, R; Lau, R; Norat, T; Savović, J; Sterne, JA; Vieira, R | 1 |
| Ahmann, FR; Algotar, AM; Clark, LC; Dalkin, BL; Graham, DL; Holmes, MA; Hsu, CH; Nagle, RB; Parnes, HL; Ranger-Moore, J; Sindhwani, P; Slate, E; Stratton, MS; Stratton, SP; Thompson, PA; Tuckey, JA | 1 |
| Chew, EY; Clemons, T | 1 |
| Fleshner, N; Hersey, K; Locke, J; Margel, D; Sorokin, K | 1 |
| Anderson, K; Arnold, KB; Baker, LH; Cook, ED; Crowley, JJ; Darke, AK; Goodman, PJ; Hartline, JA; Klein, EA; Meyskens, FL; Minasian, LM; Tangen, CM; Yee, M | 1 |
| Li, H; Loda, M; Ma, J; Mucci, LA; Penney, KL; Sesso, HD; Stampfer, MJ | 1 |
| Hesketh, J; Jansen, E; Linseisen, J; Méplan, C; Rohrmann, S; Schomburg, L; Steinbrecher, A | 1 |
| Feng, Z; Fu, R; Geybels, MS; Hutter, CM; Kwon, EM; Ostrander, EA; Peters, U; Stanford, JL | 1 |
| Abu Bakar, NF; Homayouni, N; Karimi, G; Othman, MS; Rajikan, R; Shahar, S | 1 |
| Bostwick, DG; Chiang, EC; Combs, GF; Kengeri, SS; Morris, JS; Shen, S; Waters, DJ | 1 |
| Bismarck, E; Fischer, C; Lümmen, G; Schmitz-Dräger, BJ | 1 |
| Abdulah, R; Kameo, S; Koyama, H; Yamazaki, C | 1 |
| Bishop, K; Duan, H; Ferguson, LR; Goudie, M; Han, DY; Kan, ST; Karunasinghe, N; Ko, S; Lange, K; Masters, J; Medhora, R; Wang, A; Zhu, S | 1 |
| Duffield-Lillico, AJ; Marshall, JR; Nelson, MA; Reid, M | 1 |
| Schwartz, DT | 1 |
| Tom, J | 1 |
| Cook, ED | 1 |
| Ganther, H; Jiang, C; Lü, J; Wang, Z | 1 |
| Budunova, IV; Gasparian, AV; Lü, J; Lyakh, LA; Slaga, TJ; Yao, YJ; Yemelyanov, AY | 1 |
| Graubard, BI; Greenberg, RS; Hayes, RB; Mayne, ST; Schoenberg, JB; Swanson, CA; Swanson, GM; Vogt, TM; Ziegler, RG | 1 |
| Ardern-Jones, A; Dearnaley, DP; Durocher, F; Easton, DF; Edwards, SM; Eeles, R; Hamoudi, R; Houlston, R; Jackson, RA; Kirby, R; Kote-Jarai, Z; Murkin, A | 1 |
| Bhamre, S; Cohen, HJ; Whitin, JC | 1 |
| Wians, FH; Willis, MS | 1 |
| Grönberg, H | 1 |
| Klein, EA | 5 |
| Clark, LC; Dalkin, BL; Duffield-Lillico, AJ; Jacobs, ET; Marshall, JR; Reid, ME; Slate, EH; Turnbull, BW | 1 |
| Benghuzzi, H; Hughes, J; Richards, LR; Tucci, M | 1 |
| Basler, J; Leach, R; Naylor, S; Pollock, B; Thompson, IM; Troyer, D | 1 |
| Albanes, D; Coltman, C; Goodman, PJ; Klein, EA; Lippman, SM; Taylor, PR; Thompson, IM | 2 |
| Madersbacher, S; Ponholzer, A; Struhal, G | 1 |
| Chodak, GW; Wilkinson, S | 1 |
| Bistrian, B | 1 |
| Daragó, A; Duda-Szymańska, J; Sapota, A | 1 |
| Ahmann, FR; Alberts, DS; Marshall, JR; Minter, FE; Monroe, BK; Reid, ME; Schwartzberg, G; Stratton, MS | 2 |
| Bode, P; Goldbohm, RA; van den Brandt, PA; Zeegers, MP | 1 |
| Behrendt, N; Dewailly, E; Hansen, JC; Hart Hansen, JP; Mulvad, G; Sloth Pedersen, H | 1 |
| Ip, C; Zu, K | 1 |
| Boon, H; Brown, JB; Fleshner, N; Gavin, A; Goel, V; Gray, R; Stewart, M; Westlake, K | 1 |
| Goeman, L; Joniau, S; Oyen, R; Ponette, D; Roskams, T; Van der Aa, F; Van Poppel, H | 1 |
| Lanteri, VJ; Pak, RW; Sawczuk, IS; Scheuch, JR | 1 |
| Crawford, ED | 1 |
| Albanes, D; Basler, JW; Crawford, ED; Denis, LJ; Djavan, B; Fleshner, N; Johnson-Pais, TL; Klein, EA; Kristal, AR; Lucia, MS; McMann, MC; Parnes, HL; Piazza, GA; Platz, EA; Pollock, BH; Price, DK; Reichardt, JK; Tangen, CM; Thompson, IM; Tolcher, AW | 1 |
| Barqawi, A; Crawford, ED; Thompson, IM | 1 |
| Fleshner, NE; Klotz, LH; Venkateswaran, V | 2 |
| Goulet, AC; Kagey, J; Meuillet, E; Nelson, MA; Porterfield, B; Prasad Cherukuri, D; Stratton, S | 1 |
| Ghosh, J | 1 |
| Clarke, LC; Ferguson, LR; Jamieson, M; Karunasinghe, N; Marshall, JR; Masters, J; Ryan, J; Tuckey, J | 1 |
| Basler, J; Hensley, D; Higgins, B; Jenkins, CA; Leach, R; Pollock, B; Thompson, IM; Troyer, D; von Merveldt, D | 1 |
| Dalkin, BL; Jay Gandolfi, A; Kopplin, MJ; Nagle, RB; Nyman, DW; Suzanne Stratton, M | 1 |
| Das, P; Kaplan, I | 1 |
| Allen, NE; Key, TJ; Morris, JS; Ngwenyama, RA | 1 |
| Basler, JW; Hernandez, J; Mahal, K; Thompson, IM | 2 |
| Datta, MW; Hessner, MJ; Liu, H; Schlicht, MJ; Tonellato, PJ; Wen, X; Zhou, G | 1 |
| Lucia, MS; Sakr, WA | 1 |
| Lippman, SM; Parnes, HL; Taylor, PR | 1 |
| Gaziano, JM; Giovannucci, EL; Li, H; Ma, J; Morris, JS; Stampfer, MJ; Willett, WC | 1 |
| Hubmer, G; Lipsky, K; Pummer, K; Rehak, P; Schips, L; Zigeuner, R; Zischka, M | 1 |
| Dagnelie, PC; Goldbohm, RA; Schuurman, AG; Van den Brandt, PA | 1 |
| Combs, GF | 1 |
| Fleshner, NE; Klotz, LH; Sugar, LM; Venkateswaran, V | 1 |
| Brodzeller, T; Datta, MW; Dhir, R; Hessner, MJ; Liu, H; Matysiak, B; Pollard, M; Schlicht, M; Suckow, M; Tonellato, P; Wen, X; Zhou, G | 1 |
| Clark, LC; Fakih, M; Lillico, AJ; Marshall, JR; Natarajan, R; Reid, ME; Stratton, MS | 1 |
| Hudson Priest, J; Moyad, MA; Weinrich, MC; Weinrich, SP | 1 |
| Albanes, D; Coltman, CA; Cook, ED; Crowley, JJ; Fleshner, NE; Ford, LG; Gaziano, JM; Goodman, PJ; Hoque, A; Karp, DD; Khuri, FR; Klein, EA; Kristal, AR; Lieber, MM; Lippman, SM; Minasian, LM; Moinpour, CM; Parnes, HL; Probstfield, JL; Santella, RM; Schwartz, GG; Stanford, JL; Taylor, PR; Thomas, SM; Thompson, IM; Walther, PJ | 1 |
| Kakizoe, T | 1 |
| Iwasaki, M; Tsugane, S | 1 |
| Albanes, D; Hoque, A; King, IB; Kristal, AR; Pollak, MN; Santella, RM; Stanzyk, FZ | 1 |
| Dagnelie, PC; Delaere, KP; Hoenjet, KM; Oosterhof, GO; Wijckmans, NE; Zambon, JV | 1 |
| Gaziano, JM; Giovannucci, E; Kantoff, PW; Leitzmann, MF; Li, H; Ma, J; Stampfer, MJ | 1 |
| Bloch-Boguslawska, E; Skok, Z; Szewczyk-Golec, K; Tyloch, J; Wasowicz, W; Wolski, Z; Zachara, BA | 1 |
| Bairati, I; Bertrais, S; Douville, P; Estaquio, C; Galan, P; Hercberg, S; Kegle, P; Meyer, F | 1 |
| Bostwick, DG; Combs, GF; Cooley, DM; Glickman, LT; Morris, JS; Qian, J; Shen, S; Waters, DJ | 1 |
| Chong, P; Rashid, P | 1 |
| Bloch-Boguslawska, E; Kwiatkowski, S; Stepien, S; Szewczyk-Golec, K; Szylberg, T; Tyloch, J; Wasowicz, W; Wolski, Z; Zachara, BA | 1 |
| Al Azab, R; Fleshner, N | 1 |
| Dong, Y; Gao, AC; Ip, C; Marshall, JR; Zhang, H | 1 |
| Hakenberg, OW; Wirth, MP | 1 |
| Chambers, K; Etminan, M; FitzGerald, JM; Gleave, M | 1 |
| Cho, SD; Hu, H; Jiang, C; Kang, KS; Kim, SH; Lee, YS; Li, G; Lu, J | 1 |
| Carey, AM; Martin, FL; Morris, JD; Muir, GH; Pramanik, R; Ragavan, N; Zhang, X | 1 |
| Baek, SH; Choi, KS; Ip, C; Kim, YH; Lee, JS; Ma, YB; Park, EM; Park, SY; Park, YM; Zhang, H; Zu, K | 1 |
| Cukurovali, A; Erulas, FA; Karatas, F; Ozmen, H; Yalcin, O | 1 |
| Frazee, LA; Lowe, JF | 1 |
| Ip, C; Wallace, PK; Warren, MA; Wu, Y; Zu, K | 1 |
| Herman, ZS; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Basler, JW; Caton, JR; Crawford, ED; Lee, JJ; Lerner, SP; Lippman, SM; Marshall, JR; Menter, DG; Miles, BJ; Minasian, LM; Pisters, LL; Sabichi, AL; Tangen, CM; Taylor, RJ; Thompson, IM | 1 |
| Dong, Y; Gao, AC; Ip, C; Lee, SO; Nadiminty, N; Trump, DL; Yeon Chun, J | 1 |
| Chun, JY; Gao, AC; Lee, SO; Lou, W; Nadiminty, N; Onate, SA | 1 |
| Centeno, JA; Ejnik, JW; Gray, MA; Nacey, JN; Slaney, DP; Todorov, T | 1 |
| Alberts, D; Berry, D; Coltman, C; Crawford, ED; Greenwald, P; Jarrard, D; Lieberman, R; Lippman, SM; Marshall, JR; Minasian, L; Parker, F; Sakr, W; Tangen, C; Thompson, I; Wood, D | 1 |
| Brinkman, M; Buntinx, F; Kellen, E; Reulen, RC; Zeegers, MP | 1 |
| Berry, MJ; Squires, J | 1 |
| Dillon, J; Ginsberg, R; Lavercombe, PS; See, KA | 1 |
| Theobald, S | 1 |
| Frankel, PH; Marshall, JR; Reid, ME | 1 |
| Bosello, V; Bulato, C; Maiorino, M; Ursini, F | 1 |
| Navarro Silvera, SA; Rohan, TE | 1 |
| Andriole, GL; Chanock, SJ; Chatterjee, N; Crawford, ED; Foster, CB; Hayes, RB; Peters, U; Reding, D; Schatzkin, A; Sturup, S | 1 |
| Adhami, VM; Afaq, F; Mukhtar, H; Siddiqui, IA | 1 |
| Graubard, BI; Patterson, BH; Vogt, TM; Ziegler, RG | 1 |
| Goeman, L; Joniau, S; Lerut, E; Oyen, R; Roskams, T; Van Poppel, H | 1 |
| Barzee, BR; Christensen, MJ; Hada, AL; Legg, RL; Nartey, ET | 1 |
| Thompson, IM | 1 |
| Kristal, AR; Littman, AJ; Patterson, RE; Peters, U; Potter, JD; White, E | 1 |
| Dong, Y; Liu, S; Zhang, H; Zhao, L; Zhu, L | 1 |
| Sarvis, JA; Thompson, IM | 1 |
| Mehrsai, A; Moradi, K; Nikoobakht, MR; Pourmand, G; Salem, S; Tajik, P | 1 |
| Hames, CG; Morris, JS; Polk, BF; Pressel, S; Rosner, B; Schneider, K; Stampfer, MJ; Taylor, JO; Willett, WC | 1 |
| Bergfors, M; Degerman, A; Hardell, L; Marklund, SL; Tomic, R | 1 |
| Aronson, W; Heber, D; Yip, I | 1 |
| Coltman, CA; Crowley, J; Thompson, IM | 1 |
| Albanes, D; Hartman, AM; Hartman, TJ; Pietinen, P; Rautalahti, M; Tangrea, JA; Taylor, PR | 1 |
| Borosso, C; Carpenter, D; Clark, LC; Combs, GF; Dalkin, B; Falk, S; Herlong, JH; Janosko, E; Krongrad, A; Rounder, J; Slate, EH; Turnbull, BW; Witherington, R | 1 |
| Albanes, D; Taylor, PR | 1 |
| Giovannucci, E; Morris, SJ; Rimm, EB; Spiegelman, D; Stampfer, MJ; Willett, WC; Yoshizawa, K | 1 |
| Giovannucci, E | 1 |
| Herschberg, PI | 1 |
| Clark, LC; Jacobs, ET; Nelson, MA; Porterfield, BW | 1 |
| Fair, WR; Lee, CT | 1 |
| Clinton, SK | 1 |
| Clark, LC; Lin, H; McCulloch, CE; Slate, EH; Turnbull, BW | 1 |
| Brawley, OW; Parnes, H | 1 |
| Combs, GF; Lee, J; Nomura, AM; Stemmermann, GN | 1 |
| Boyle, P; Ghadirian, P; Kennedy, G; Krewski, D; Lacroix, A; Maisonneuve, P; Perret, C | 1 |
| Calvert, RC; Mikhailidis, DP; Morgan, RJ; Thompson, CS | 1 |
| Lippman, SM; Menter, DG; Sabichi, AL | 1 |
| Blumenfeld, AJ; Casselman, B; Fleshner, N; Trachtenberg, J | 1 |
| Alberg, AJ; Burke, A; Comstock, GW; Helzlsouer, KJ; Hoffman, S; Huang, HY; Morris, JS; Norkus, EP | 1 |
| Marshall, JR | 2 |
| Fleshner, NE; Kucuk, O | 1 |
| Brooks, JD; Williams, ED | 1 |
| Costello, AJ | 1 |
| Cohen, LA; Rose, DP; Wynder, EL | 1 |
| Abbou, CC; Chopin, DK; Cicco, A; de la Taille, A; Katz, A; Saint, F; Salomon, L; Vacherot, F | 1 |
| Beiche, B; Ebert, T; Eichholzer, M; Schmitz-Dräger, BJ | 1 |
| Miller, M | 1 |
| Brooks, JD; DePrimo, SE; Shinghal, R; Vidanes, G | 1 |
| Albanes, D; Coltman, CA; Crowley, JJ; Goodman, P; Hoque, A; Klein, EA; Lippman, SM; Santella, RM; Spitz, MR; Stanford, JL; Taylor, PR; Thompson, IM | 1 |
| Bankson, DD; Goodman, GE; Hughes, MP; Omenn, GS; Schaffer, S | 1 |
| Helzlsouer, KJ; Platz, EA | 1 |
| Bubley, GJ; Ko, YJ | 1 |
| DeFrancesco, L | 1 |
| Andres, R; Brooks, JD; Carter, HB; Chan, DW; Landis, P; Metter, EJ; Muller, D; Nelson, WG; Sokoll, LJ | 1 |
| Barnes, S; Brawley, OW; Parnes, H | 1 |
| Lin, H; McCulloch, CE; Slate, EH; Turnbull, BW | 1 |
| Ackermann, R; Jankevicius, F; Miller, SM | 1 |
| Chang, E; Messing, EM; Ni, J; Yang, CR; Yeh, S; Zhang, Y | 1 |
| Cohen, LA | 1 |
| Hirose, M; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Takahashi, S | 1 |
| French, TK; Mahoney, AW; Robison, LM; Slattery, ML; West, DW | 1 |
| Filev, A; Kumanov, Kh; Mladenov, D; Tsachev, K; Tsvetkov, M | 1 |
| McTiernan, A; Vaughan, TL | 1 |
| Dittrich, H; Feustel, A; Wennrich, R | 1 |
| James, GT; Perez-Ripoll, EA; Webber, MM | 1 |
103 review(s) available for selenium and Cancer of Prostate
| Article | Year |
|---|---|
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential.
Topics: Humans; Male; Necroptosis; Prostatic Neoplasms; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases; Selenium | 2022 |
Role of SELENBP1 and SELENOF in prostate cancer bioenergetics.
Topics: Energy Metabolism; Humans; Male; Prostatic Neoplasms; Selenium; Selenium-Binding Proteins; Selenocysteine; Selenoproteins | 2022 |
Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Dogs; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium | 2018 |
The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis
Topics: Antioxidants; Case-Control Studies; Humans; Male; Prognosis; Prostatic Neoplasms; Selenium | 2018 |
Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).
Topics: Aged; Animals; Anticarcinogenic Agents; Dietary Supplements; Drug Combinations; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Time Factors; Treatment Outcome; Vitamin E | 2013 |
Advances in prostate cancer chemoprevention: a translational perspective.
Topics: Androgen Antagonists; Animals; Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Curcumin; Disease Models, Animal; Dutasteride; Finasteride; Flavonoids; Genistein; Humans; Lycopene; Male; Phytochemicals; Polyphenols; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Silybin; Silymarin; Tea; Vitamin E | 2013 |
[Pharmaco and diet based prostate cancer prevention].
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Diet; Eflornithine; Fruit; Histone Deacetylase Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metformin; Minerals; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Vegetables; Vitamin D; Vitamin E; Vitamins | 2013 |
Review of selenium and prostate cancer prevention.
Topics: Animals; Antioxidants; Humans; Male; Prostatic Neoplasms; Selenium | 2013 |
Prostate cancer chemoprevention.
Topics: Adrenergic alpha-Antagonists; Animals; Anticarcinogenic Agents; Chemoprevention; Diet; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2013 |
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Topics: Aged; Case-Control Studies; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Incidence; Male; Middle Aged; Neoplasm Grading; Odds Ratio; Phospholipids; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Treatment Failure; United States; Vitamin E | 2013 |
Dietary antioxidants and prostate cancer: a review.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Coffee; Diet; Dietary Supplements; gamma-Tocopherol; Humans; Lycopene; Male; Polyphenols; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Tea; United States | 2013 |
Complementary and alternative medicine (CAM) in prostate and bladder cancer.
Topics: Acupuncture; Antineoplastic Agents; Antioxidants; Camellia sinensis; Complementary Therapies; Drugs, Chinese Herbal; Female; Humans; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Urinary Bladder Neoplasms; Vitamin E; Vitamins | 2013 |
Chemoprevention of prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Dietary Supplements; Dutasteride; Finasteride; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Lycopene; Male; Plant Extracts; Primary Prevention; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Serenoa; Vitamin E | 2014 |
Future directions in the prevention of prostate cancer.
Topics: Antioxidants; Clinical Trials as Topic; Forecasting; Humans; Male; Primary Prevention; Prostatic Neoplasms; Selenium; Vitamin E | 2014 |
Prevention of prostate cancer: outcomes of clinical trials and future opportunities.
Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Finasteride; Humans; Inflammation; Male; Middle Aged; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin E | 2014 |
Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Topics: Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin D; Vitamin E | 2014 |
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.
Topics: Androgen Antagonists; Calcium, Dietary; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids; Humans; Male; Osteoporosis; Phytoestrogens; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin D; Vitamin E | 2014 |
Selenium and vitamin E for prostate cancer--justifications for the SELECT study.
Topics: Antioxidants; Cell Transformation, Neoplastic; Dietary Supplements; Humans; Male; Oxidative Stress; Prostatic Neoplasms; Selenium; Vitamin E | 2015 |
Relation of Vitamin E and Selenium Exposure to Prostate Cancer Risk by Smoking Status: A Review and Meta-Analysis.
Topics: Humans; Male; Prostatic Neoplasms; Regression Analysis; Risk Factors; Selenium; Smoking; Vitamin E | 2015 |
Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; Animals; Animals, Zoo; Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Antimanic Agents; Antioxidants; Aortic Valve; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bacillus; Bacterial Toxins; Bacterial Typing Techniques; Base Composition; Beauveria; Binge Drinking; Biomarkers; Bipolar Disorder; Blood Coagulation; Blotting, Western; Brachytherapy; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Wall; Cells, Cultured; Ceramics; Chi-Square Distribution; China; Chlorophyll; Chlorophyta; Chloroplasts; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromobacterium; Clostridium perfringens; Clozapine; Constriction, Pathologic; Coronary Artery Bypass; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dental Porcelain; Dental Restoration Failure; Dental Stress Analysis; Designer Drugs; Diaminopimelic Acid; DNA Fingerprinting; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Dosage Calculations; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Elasticity Imaging Techniques; Epsilonproteobacteria; Equipment Design; Ericaceae; Excitatory Amino Acid Antagonists; False Negative Reactions; Fatty Acids; Female; Food Analysis; Fresh Water; Gene Expression Regulation, Neoplastic; Glutathione; Graft Occlusion, Vascular; Heart Valve Prosthesis Implantation; Heart Ventricles; HEK293 Cells; Hemolymph; Humans; Hyaluronan Receptors; Hydrogen Peroxide; Hydrothermal Vents; Indoles; Inflammation Mediators; Inhibitory Concentration 50; Insecta; International Normalized Ratio; Isotope Labeling; Itraconazole; Kidney; Kinetics; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lamotrigine; Lanthanoid Series Elements; Limit of Detection; Linear Models; Lipid Peroxidation; Liver; Liver Cirrhosis; Logistic Models; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Malondialdehyde; Mediastinum; Metronidazole; Mice; Mice, Nude; Mice, Transgenic; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Monocytes; Monomeric GTP-Binding Proteins; Multivariate Analysis; Myocytes, Cardiac; Neoplasm Staging; Neoplastic Stem Cells; Neural Pathways; Nitrates; Nucleic Acid Hybridization; Octamer Transcription Factor-3; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Peptidoglycan; Phantoms, Imaging; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Phospholipids; Photolysis; Photosynthesis; Phylogeny; Plant Extracts; Polychaeta; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyrimidines; Pyrroles; Quorum Sensing; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reference Values; Regression Analysis; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhizosphere; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Rutin; Saphenous Vein; Seawater; Selenium; Semen Preservation; Sensitivity and Specificity; Septal Nuclei; Sequence Analysis, DNA; Serum Albumin; Serum Albumin, Human; Shear Strength; Sodium Pertechnetate Tc 99m; Sodium-Hydrogen Exchangers; Soil Microbiology; SOXB1 Transcription Factors; Spain; Species Specificity; Sperm Motility; Spermatozoa; Spheroids, Cellular; Spores, Fungal; Stroke; Superoxide Dismutase; Swine; Tandem Mass Spectrometry; Technetium Compounds; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Temperature; Thiosulfates; Thrombosis; Thyroid Neoplasms; Transducers; Transfection; Transplantation, Heterologous; Treatment Outcome; Triazines; Tumor Burden; Urocortins; Uterine Cervical Neoplasms; Vacuoles; Valproic Acid; Ventral Tegmental Area; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin; Water Microbiology; Young Adult | 2016 |
Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis.
Topics: Biomarkers, Tumor; Humans; Male; Neoplasm Grading; Neoplasm Staging; Observational Studies as Topic; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2017 |
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Carotenoids; Humans; Lycopene; Male; Phytotherapy; Prostatic Diseases; Prostatic Neoplasms; Selenium; Serenoa | 2008 |
Mechanisms of selenium chemoprevention and therapy in prostate cancer.
Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine | 2008 |
Selenium and the prevention of prostate and colorectal cancer.
Topics: Anti-Inflammatory Agents; Antioxidants; Clinical Trials as Topic; Cohort Studies; Colorectal Neoplasms; Female; Humans; Incidence; Inflammation; Male; Prostatic Neoplasms; Risk Factors; Selenium; Smoking; United States | 2008 |
Can the Mediterranean diet prevent prostate cancer?
Topics: beta Carotene; Calcium, Dietary; Carotenoids; Diet, Mediterranean; Dietary Fats; Humans; Incidence; Lycopene; Male; Prostatic Neoplasms; Selenium; Vegetables; Vitamin D | 2009 |
Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.
Topics: Antioxidants; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Prostate cancer: a serious disease suitable for prevention.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Toremifene; Vitamin E | 2009 |
Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.
Topics: Anticarcinogenic Agents; Humans; Male; Prostatic Neoplasms; Selenium; Selenium Compounds | 2009 |
Chemoprevention of prostate cancer: what can be recommended to patients?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoflavones; Male; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin D; Vitamin E; Vitamins | 2009 |
Cancer prevention: from 1727 to milestones of the past 100 years.
Topics: Cancer Vaccines; History, 18th Century; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Male; Neoplasms; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?
Topics: Antioxidants; Humans; Male; Prostatic Neoplasms; Radiation Injuries; Selenium | 2010 |
[Chemical prevention of prostatic neoplasms].
Topics: 5-alpha Reductase Inhibitors; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2010 |
Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2010 |
Use of transgenic mice as models for prostate cancer chemoprevention.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Male; Mice; Mice, Transgenic; Models, Animal; Prostate; Prostatic Neoplasms; Selenium; Vitamin E | 2010 |
The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.
Topics: Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Male; Minerals; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins; Zinc | 2011 |
Methods to predict and lower the risk of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Chemoprevention; Humans; Male; Prostatic Neoplasms; Risk Reduction Behavior; Selenium; Vitamin E | 2011 |
Molecular targets of selenium in prostate cancer prevention (Review).
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; Selenium; Signal Transduction | 2011 |
Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America.
Topics: Arsenic; Calcium; Carotenoids; Dairy Products; Eggs; Epidemiologic Studies; Feeding Behavior; Fruit; Humans; Lycopene; Male; Meat; Prostatic Neoplasms; Risk Factors; Selenium; Solanum lycopersicum; South America; Vegetables | 2012 |
Chemoprevention of prostate cancer: an updated view.
Topics: 5-alpha Reductase Inhibitors; Chemoprevention; Humans; Male; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin E; Vitamins | 2012 |
Complementary and alternative medicines in prostate cancer: from bench to bedside?
Topics: Antioxidants; Beverages; Complementary Therapies; Curcuma; Humans; Lythraceae; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Tea; Vitamin E; Vitamins | 2012 |
Selenium and prostate cancer: systematic review and meta-analysis.
Topics: Adult; Diet; Humans; Male; Nails; Nutritional Status; Prostatic Neoplasms; Risk Factors; Selenium | 2012 |
Prevention strategies for prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Dairy Products; Diet; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Male; Meat; Phytoestrogens; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Selenium; Smoking Cessation; Vitamins | 2012 |
[Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2013 |
Prostate cancer and selenium.
Topics: Clinical Trials as Topic; Humans; Life Expectancy; Male; Prostatic Neoplasms; Selenium | 2002 |
Serum selenium and risk of prostate cancer in U.S. blacks and whites.
Topics: Adult; Aged; Black People; Case-Control Studies; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; United States; Vitamin E; White People | 2003 |
The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances.
Topics: Antioxidants; Calcium, Dietary; Cell Division; Diet; Dietary Fats; Humans; Male; Nutritional Physiological Phenomena; Phenols; Prostatic Neoplasms; Selenium; Signal Transduction; Soybean Proteins; Vitamins | 2003 |
Prostate cancer epidemiology.
Topics: Adult; Aged; Diet; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium | 2003 |
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.
Topics: Antioxidants; Chemoprevention; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Vitamin E | 2003 |
The selenium and vitamin E cancer prevention trial.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2003 |
Critical review of complementary therapies for prostate cancer.
Topics: Antineoplastic Agents, Phytogenic; Complementary Therapies; Dietary Fats; Dietary Supplements; Drugs, Chinese Herbal; Humans; Male; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Selenium; Vitamins | 2003 |
Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Antioxidants; Chemoprevention; Clinical Trials as Topic; Humans; Male; Middle Aged; Models, Biological; Prostatic Neoplasms; Selenium; Vitamin E | 2003 |
Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Topics: Antioxidants; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2002 |
Epidemiology of prostate cancer.
Topics: Age Factors; Black or African American; Carotenoids; Diet; Disease Susceptibility; Family; Humans; Incidence; Lycopene; Male; Mass Screening; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium | 2003 |
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement.
Topics: Anticarcinogenic Agents; Antioxidants; Humans; Male; Prostatic Neoplasms; Research Design; Selenium; Vitamin E | 2004 |
Prostate cancer chemoprevention: an overview of United States trials.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cyclooxygenase 2; Humans; Isoenzymes; Male; Membrane Proteins; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Selenium; United States | 2004 |
Selenium: epidemiology and basic science.
Topics: Animals; Antioxidants; Humans; Male; Methylation; Molecular Epidemiology; Prostatic Neoplasms; Selenium | 2004 |
Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Topics: Clinical Trials as Topic; Drug Evaluation, Preclinical; Eligibility Determination; Humans; Male; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Selenium; Sodium Selenite; Vitamin E | 2004 |
Prostate cancer prevention: what do we know now and when will we know more?
Topics: Antioxidants; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Predictive Value of Tests; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E | 2003 |
The role of PC-SPES, selenium, and vitamin E in prostate cancer.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Clinical Trials as Topic; Complementary Therapies; Drugs, Chinese Herbal; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2002 |
What's new in the field of prostate cancer chemoprevention?
Topics: Antioxidants; Chemoprevention; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2004 |
Update on chemoprevention of prostate cancer.
Topics: Aged; Carotenoids; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Middle Aged; Prevalence; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tea; United States; Vitamin D; Vitamin E | 2004 |
Potential pathologic markers for prostate chemoprevention studies.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Chemoprevention; Dietary Supplements; Humans; Male; Middle Aged; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Assessment; Selenium; Sensitivity and Specificity; Survival Analysis; Vitamin E | 2004 |
Science peels the onion of selenium effects on prostate carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Dietary Supplements; DNA Damage; DNA, Neoplasm; Humans; Incidence; Male; Prostatic Neoplasms; Proteins; Randomized Controlled Trials as Topic; Selenium; Selenoproteins; Vitamin E | 2004 |
Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies.
Topics: Anthropometry; Calcium, Dietary; Diet; Humans; Male; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium | 2004 |
Status of selenium in prostate cancer prevention.
Topics: Animals; Humans; Male; Prostatic Neoplasms; Selenium | 2004 |
[Prostate cancer. Introduction].
Topics: 5-alpha Reductase Inhibitors; alpha-Tocopherol; Antineoplastic Agents, Hormonal; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Finasteride; Genetic Therapy; Humans; Male; Neoadjuvant Therapy; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Selenium | 2005 |
[Risk factors and current chemoprevention studies in prostate cancer].
Topics: 5-alpha Reductase Inhibitors; beta Carotene; Dairy Products; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Exercise; Finasteride; Fish Oils; Humans; Life Style; Male; Meat; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E | 2005 |
Selenium and vitamin E cancer prevention trial.
Topics: Black People; Humans; Male; Middle Aged; National Institutes of Health (U.S.); Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E; White People | 2004 |
Can we prevent prostate cancer?
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Ascorbic Acid; Complementary Therapies; Dietary Supplements; Health Behavior; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Risk Factors; Selenium; Serenoa; Soy Foods; Tea; Vitamin E | 2005 |
What's new in the field of prostate cancer chemoprevention?
Topics: Antineoplastic Agents; Chemoprevention; Clinical Protocols; Cyclooxygenase Inhibitors; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2005 |
Prostate cancer: chemoprevention update 2005.
Topics: alpha-Tocopherol; Antineoplastic Agents; Antioxidants; Carotenoids; Enzyme Inhibitors; Glycine max; Humans; Lycopene; Male; Phytotherapy; Prostatic Neoplasms; Selenium; Treatment Outcome | 2005 |
[Prevention of prostate cancer].
Topics: 5-alpha Reductase Inhibitors; Animals; Anticarcinogenic Agents; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Fishes; Flavonoids; Fruit; Humans; Isoflavones; Lycopene; Male; Neoplasms, Hormone-Dependent; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Soy Milk; Tea; Vegetables; Vitamin D; Vitamin E | 2005 |
Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis.
Topics: Canada; Chemoprevention; Humans; Male; Prostatic Neoplasms; Risk; Risk Assessment; Risk Factors; Selenium | 2005 |
Can prostate cancer be prevented?
Topics: Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2005 |
Update on prostate cancer chemoprevention.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins | 2006 |
[Prostate cancer chemoprevention].
Topics: Carotenoids; Drug Therapy; Enzyme Inhibitors; Finasteride; Humans; Isoflavones; Lycopene; Male; Prostatic Neoplasms; Selenium; Soy Foods; Vitamin A; Vitamin D; Vitamin E | 2005 |
Are men with low selenium levels at increased risk of prostate cancer?
Topics: Humans; Male; Nails; Prostatic Neoplasms; Regression Analysis; Risk Factors; Selenium | 2006 |
Selenium, selenoproteins, and cancer.
Topics: Animals; Breast Neoplasms; Chemoprevention; Female; Gene Expression; Humans; Male; Neoplasms; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Selenoproteins | 2006 |
[Nutrition and prostate cancer--what is the scientific evidence?].
Topics: Diet; Humans; Male; Neoplasm Recurrence, Local; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium | 2006 |
Trace elements and cancer risk: a review of the epidemiologic evidence.
Topics: Arsenic; Breast Neoplasms; Cadmium; Environmental Exposure; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Risk Factors; Selenium; Trace Elements; Zinc | 2007 |
Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
Topics: Anticarcinogenic Agents; Cyclooxygenase 2; Diet; Humans; Lythraceae; Male; Ornithine Decarboxylase; Pentacyclic Triterpenes; Prostatic Neoplasms; Selenium; Tea; Tocopherols; Triterpenes | 2008 |
Chemoprevention of prostate cancer: agents and study designs.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Carotenoids; Dietary Fats; Humans; Lycopene; Male; Prostatic Neoplasms; Selenium; Tocopherols; Toremifene | 2007 |
Androgens and prevention of prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Azasteroids; Dutasteride; Finasteride; Humans; Male; Prostate; Prostatic Neoplasms; Selenium; Signal Transduction; Vitamin E | 2008 |
Nutritional approaches to the prevention of prostate cancer progression.
Topics: Animals; Dietary Fats; Dietary Fiber; Humans; Male; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium; Soybean Proteins; Vitamin E | 1996 |
Diet and prostate cancer: more on selenium and other nutrients.
Topics: Calcium; Dietary Fats; Dietary Supplements; Fructose; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Vitamins | 1998 |
Selenium and prostate cancer prevention.
Topics: Cell Division; Chemoprevention; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Male; Primary Prevention; Prostatic Neoplasms; Risk Factors; Selenium; Tumor Cells, Cultured | 1999 |
The role of dietary manipulation in biochemical recurrence of prostate cancer after radical prostatectomy.
Topics: Diet; Dietary Fats; Glycine max; Humans; Isoflavones; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Selenium; Vitamins | 1999 |
Prostate cancer prevention trials in the USA.
Topics: 5-alpha Reductase Inhibitors; Aged; Animals; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Rabbits; Risk Factors; Selenium; Vitamin E | 2000 |
Nutritional aspects of prostate cancer: a review.
Topics: Calcium, Dietary; Carotenoids; Estrogens, Non-Steroidal; Fatty Acids; Humans; Isoflavones; Male; Nutritional Physiological Phenomena; Phytoestrogens; Plant Preparations; Plants, Edible; Prostatic Neoplasms; Selenium; Soybean Proteins; Vegetables; Vitamin D; Vitamin E | 2000 |
High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research.
Topics: Anticarcinogenic Agents; Antioxidants; Biomarkers, Tumor; Drug Evaluation; Humans; Male; Predictive Value of Tests; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium | 2001 |
Nutrition and prostate cancer: a proposal for dietary intervention.
Topics: Animals; Dietary Fats; Dietary Supplements; Disease Models, Animal; Glycine max; Humans; Male; Prospective Studies; Prostatic Neoplasms; Retrospective Studies; Selenium; Tumor Cells, Cultured; Vitamin E | 1994 |
[Cancer of the prostate: influence of nutritional factors. Vitamins, antioxidants and trace elements].
Topics: Aged; Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cadmium; Carotenoids; Clinical Trials as Topic; Cohort Studies; Follow-Up Studies; Humans; Lycopene; Male; Mice; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Solanum lycopersicum; Time Factors; Trace Elements; Tumor Cells, Cultured; Vitamin A; Vitamin D; Vitamin E; Vitamins | 2001 |
Nutrition and prostate cancer.
Topics: Carotenoids; Diet; Dietary Fats; Estrogens, Non-Steroidal; Humans; Isoflavones; Lycopene; Male; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Selenium; Vitamins | 2001 |
Prostate cancer: epidemiology and prevention.
Topics: Animals; Clinical Trials as Topic; Humans; Male; Meat; Nutritional Physiological Phenomena; Prospective Studies; Prostatic Neoplasms; Selenium; Vitamin E | 2000 |
Prevention of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Androgen Antagonists; Androgens; Animals; Anticarcinogenic Agents; Antioxidants; Carotenoids; Case-Control Studies; Cohort Studies; Dietary Fats; Double-Blind Method; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Humans; Incidence; Insulin-Like Growth Factor I; Life Style; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neoplasms, Hormone-Dependent; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Soybean Proteins; Vitamin D; Vitamin E | 2001 |
Selenium, zinc, and prostate cancer.
Topics: Cell Transformation, Neoplastic; Epidemiologic Studies; Humans; Male; Prostatic Neoplasms; Selenium; Zinc | 2001 |
Prostate cancer in the older man.
Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Antioxidants; Brachytherapy; Dietary Fats; Humans; Male; Middle Aged; Mitoxantrone; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Selenium; Tosyl Compounds; Vitamin E | 2001 |
The future of prostate cancer prevention.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Anticarcinogenic Agents; Antioxidants; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diet; Double-Blind Method; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Selenium; Soybean Proteins; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E | 2001 |
Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Topics: Antioxidants; Arizona; Cohort Studies; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium | 2001 |
Nutrition and risk of prostate cancer.
Topics: Antioxidants; Ascorbic Acid; Carotenoids; Diet; Dietary Fats; Estrogens, Non-Steroidal; Humans; Isoflavones; Male; Meat; Phytoestrogens; Plant Preparations; Plants; Prostatic Neoplasms; Selenium; Tocopherols; Vitamin A; Vitamin D; Vitamin E | 2002 |
Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
Topics: beta Carotene; Comorbidity; Dietary Supplements; Female; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Smoking; Vitamin E | 2002 |
Nutrition and prostate cancer: a review.
Topics: Carotenoids; Diet; Glycine max; Humans; Isoflavones; Lycopene; Male; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium | 2002 |
Diet in the etiology of cancer.
Topics: Breast Neoplasms; Carcinogens; Colonic Neoplasms; Diet; Dietary Fats; Dietary Fiber; Epidemiologic Methods; Female; Food Additives; Humans; Male; Neoplasms; Prostatic Neoplasms; Records; Risk; Selenium; Vitamin A; Vitamins | 1986 |
40 trial(s) available for selenium and Cancer of Prostate
| Article | Year |
|---|---|
Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats.
Topics: Androgens; Animals; Antioxidants; Carcinogenesis; Carcinogens; Diet; Disease Models, Animal; Humans; Male; Mice; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Selenomethionine | 2022 |
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Biopsy; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins | 2022 |
Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial.
Topics: Aged; Anticarcinogenic Agents; Biopsy; Carotenoids; Dietary Supplements; Humans; Incidence; Lycopene; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium | 2017 |
Selenium supplementation has no effect on serum glucose levels in men at high risk of prostate cancer.
Topics: Aged; Aged, 80 and over; Blood Glucose; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk; Selenium | 2013 |
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Topics: Aged; Case-Control Studies; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Incidence; Male; Middle Aged; Neoplasm Grading; Odds Ratio; Phospholipids; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Treatment Failure; United States; Vitamin E | 2013 |
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Adult; Case-Control Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk; Selenium; Vitamin D; Vitamin E; Vitamins | 2014 |
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Case-Control Studies; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium; Tocopherols | 2014 |
Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium | 2014 |
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Topics: Anticarcinogenic Agents; Antioxidants; Biological Availability; Biopsy; Carotenoids; Chemoprevention; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Monitoring; Humans; Lycopene; Male; Prostate; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Treatment Outcome | 2015 |
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Anticarcinogenic Agents; Black or African American; Body Mass Index; Canada; Chi-Square Distribution; Health Status Disparities; Humans; Incidence; Male; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Puerto Rico; Risk Assessment; Risk Factors; Selenium; Time Factors; Treatment Outcome; United States; Vitamin E; White People | 2015 |
Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Topics: Aged; Biological Transport; Biomarkers, Tumor; Cohort Studies; Genetic Variation; Humans; Male; Middle Aged; Neoplasm Grading; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2016 |
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.
Topics: Aged; Carotenoids; Diet; Fatty Acids, Omega-3; Fruit and Vegetable Juices; Glycine max; Humans; Isoflavones; Lycopene; Lythraceae; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Solanum lycopersicum; Vitis | 2017 |
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; Databases, Factual; Double-Blind Method; Endpoint Determination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Research Design; Retrospective Studies; Risk Factors; Selenium; Time Factors; Treatment Outcome; United States; Vitamin E | 2016 |
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; alpha-Tocopherol; Antioxidants; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Selenium; Selenomethionine; Treatment Outcome; Vitamin E | 2009 |
Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma; Dietary Supplements; Disease Progression; Double-Blind Method; Humans; Male; Middle Aged; Placebos; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium | 2010 |
No effect of selenium supplementation on serum glucose levels in men with prostate cancer.
Topics: Aged; Blood Glucose; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Selenium; Trace Elements | 2010 |
Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Selenium; Yeasts | 2011 |
Selenium glycinate supplementation increases blood glutathione peroxidase activities and decreases prostate-specific antigen readings in middle-aged US men.
Topics: Adult; Dietary Supplements; Double-Blind Method; Erythrocytes; Glutathione Peroxidase; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium; United States | 2011 |
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Topics: Disease Progression; Disease-Free Survival; Double-Blind Method; Humans; Male; Middle Aged; Patient Compliance; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Soybean Proteins; Testosterone; Vitamin E | 2011 |
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Topics: Aged; Antioxidants; Dietary Supplements; Disease Progression; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Treatment Outcome | 2011 |
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Antioxidants; Dietary Supplements; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Risk; Selenium; Vitamin E | 2011 |
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Topics: Administration, Oral; Aged; Biopsy; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium | 2013 |
Moving a randomized clinical trial into an observational cohort.
Topics: Adult; Aged; Aged, 80 and over; Canada; Clinical Trials Data Monitoring Committees; Cohort Studies; Data Collection; Dietary Supplements; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Follow-Up Studies; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Placebos; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Research Design; Selenium; United States; Vitamin E | 2013 |
Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.
Topics: Aging; Animals; Apoptosis; Cell Proliferation; Dietary Supplements; Dihydrotestosterone; DNA Damage; Dogs; Homeostasis; Male; Models, Animal; Prostate; Prostatic Neoplasms; Selenium; Selenomethionine; Testosterone; Yeasts | 2012 |
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Topics: Biopsy; Dietary Supplements; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Selenium | 2003 |
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Topics: Aged; Alkaline Phosphatase; Anticarcinogenic Agents; Biomarkers, Tumor; Chromogranin A; Chromogranins; Dietary Supplements; Double-Blind Method; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Yeasts | 2003 |
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
Topics: Aged; Anticarcinogenic Agents; Dietary Supplements; Disease Progression; Double-Blind Method; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Yeasts | 2003 |
Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
Topics: Aged; Biopsy, Needle; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2003 |
A report of high-dose selenium supplementation: response and toxicities.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prostatic Neoplasms; Saccharomyces cerevisiae; Selenium; Time Factors | 2004 |
Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Coenzymes; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Ubiquinone; Vitamin E | 2005 |
Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Topics: Adult; Aged; Antioxidants; Dietary Supplements; Drug Administration Schedule; Humans; Male; Middle Aged; Placebos; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Somatomedins; Zinc | 2005 |
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Neoplasms; Selenium; Selenomethionine; Seminal Vesicles; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors; Tissue Distribution | 2006 |
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Clinical Trials as Topic; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Neoplasm Staging; Placebos; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Research Design; Selenium | 2006 |
Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
Topics: Adult; Aged; Dietary Supplements; Follow-Up Studies; Humans; Isoflavones; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Soy Foods; Treatment Outcome; Vitamin E | 2007 |
Prediagnostic serum selenium and risk of cancer.
Topics: Adult; Aged; Black People; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Risk; Selenium; United States; Vitamin A; Vitamin E; White People | 1983 |
Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Vitamin D; Vitamin E | 1997 |
The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
Topics: Aged; beta Carotene; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Smoking; Vitamin E | 1998 |
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Treatment Outcome | 1998 |
A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues.
Topics: Aged; Antioxidants; Humans; Male; Middle Aged; Patient Selection; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Selenium; Victoria | 2001 |
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Colorectal Neoplasms; Double-Blind Method; Epidemiologic Studies; Genetic Markers; Gonadal Steroid Hormones; Humans; Leptin; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium; United States; Vitamin E | 2001 |
191 other study(ies) available for selenium and Cancer of Prostate
| Article | Year |
|---|---|
Boosting and lassoing new prostate cancer SNP risk factors and their connection to selenium.
Topics: Algorithms; Alleles; Antineoplastic Agents; Humans; Logistic Models; Male; Prostatic Neoplasms; Risk Factors; Selenium | 2021 |
Diagnosis of Prostate Cancer and Prostatitis Using near Infra-Red Fluorescent AgInSe/ZnS Quantum Dots.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Humans; Indium; Male; Mammary Neoplasms, Animal; Mice; Prostatic Neoplasms; Prostatitis; Quantum Dots; Selenium; Silver; Staphylococcus aureus; Sulfides; Water; Zinc Compounds | 2021 |
Au-Se bonded nanoprobe for prostate specific antigen detection in serum.
Topics: Biosensing Techniques; Gold; Humans; Limit of Detection; Male; Metal Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium | 2022 |
Association between serum heavy metals and prostate cancer risk - A multiple metal analysis.
Topics: Aged; Arsenic; Bayes Theorem; Biological Monitoring; Humans; Male; Metals, Heavy; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium; Singapore | 2019 |
Inflammation factors and element supplementation in cancer.
Topics: Animals; Cytokines; Dietary Supplements; Disease Models, Animal; Inflammation; Iron; Male; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Selenium; Zinc | 2020 |
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Coculture Techniques; Drug Liberation; Drug Screening Assays, Antitumor; Durapatite; Humans; Kinetics; Male; Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Selenium; Stem Cells; Surface Properties; Tumor Cells, Cultured | 2020 |
Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin D1; Disease-Free Survival; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Nanoparticles; Prognosis; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Selenium; Up-Regulation | 2020 |
Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Topics: Biomarkers, Tumor; Case-Control Studies; Cohort Studies; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Nails; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Selenium; Selenoprotein P | 2021 |
Circulating Vitamin D and Selenium Levels and Outcome in Prostate Cancer Patients: Lessons from the MARTINI-Lifestyle Cohort.
Topics: Disease-Free Survival; Humans; Life Style; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Selenium; Vitamin D | 2021 |
Selenium nanoparticles inhibit tumor metastasis in prostate cancer through upregulated miR-155-5p-related pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Feedback, Physiological; Humans; Male; Mice; MicroRNAs; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Prostatic Neoplasms; Selenium; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |
Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation.
Topics: Adenocarcinoma; Antineoplastic Agents; Bacillus licheniformis; Cell Death; Cell Line, Tumor; Humans; Male; Nanoparticles; Necrosis; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Selenium; Tumor Necrosis Factor-alpha | 2017 |
Levels of plasma selenium and urinary total arsenic interact to affect the risk for prostate cancer.
Topics: Aged; Arsenic; Case-Control Studies; Humans; Male; Prostatic Neoplasms; Selenium | 2017 |
Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
Topics: Adult; Aged; Blotting, Western; Cell Line, Tumor; Ethnicity; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prostate; Prostatic Neoplasms; Selenium; Selenoprotein P; Selenoproteins; Tissue Array Analysis | 2018 |
Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
Topics: Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Male; Mendelian Randomization Analysis; Odds Ratio; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium | 2018 |
Plasmonic Cu
Topics: Antibodies, Immobilized; Biomarkers, Tumor; Catalysis; Click Chemistry; Copper; Humans; Immunoassay; Male; Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Selenium; Spectrum Analysis, Raman; Sulfur | 2018 |
Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling.
Topics: Cell Degranulation; Cytotoxicity, Immunologic; DNA Damage; Fas Ligand Protein; fas Receptor; Humans; Immunotherapy; Killer Cells, Natural; Male; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Death Domain; Ruthenium; Selenium; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2019 |
Advanced prostate cancer risk in relation to toenail selenium levels.
Topics: Aged; Antioxidants; Humans; Incidence; Male; Middle Aged; Nails; Neoplasm Staging; Netherlands; Odds Ratio; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Surveys and Questionnaires; Trace Elements | 2013 |
Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Cohort Studies; Genetic Predisposition to Disease; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Male; Middle Aged; Nails; Neoplasm Staging; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Selenoproteins | 2014 |
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
Topics: Aged; Antioxidants; Black or African American; Canada; Cohort Studies; Dietary Supplements; Humans; Male; Middle Aged; Nails; Neoplasm Grading; Odds Ratio; Proportional Hazards Models; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Risk; Selenium; Trace Elements; United States; Vitamin E; Vitamins | 2014 |
Baseline selenium and prostate cancer risk: comments and open questions.
Topics: Antioxidants; Black or African American; Dietary Supplements; Humans; Male; Nails; Prostatic Neoplasms; Selenium; Vitamin E | 2014 |
Prostate cancer: new data on risks of selenium and vitamin E.
Topics: Antioxidants; Black or African American; Dietary Supplements; Humans; Male; Nails; Prostatic Neoplasms; Selenium; Selenoproteins; Vitamin E | 2014 |
[High doses of selenium and vitamin E administration increased risk of cancer].
Topics: Humans; Male; Neoplasms; Prostatic Neoplasms; Risk; Selenium; Vitamin E; Vitamins | 2014 |
Selenium and vitamin E raise risk of prostate cancer.
Topics: Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E; Vitamins | 2014 |
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Topics: Aged; Antioxidants; Biomarkers, Tumor; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk; Selenium; Selenoproteins | 2015 |
On call. In the May 2014 issue, you reported on findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), which said that taking vitamin E and selenium raises the risk of prostate cancer. My multivitamin contains both of these nutrients
Topics: Antioxidants; Dietary Supplements; Health Behavior; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2014 |
Selenium supplementation and prostate cancer mortality.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Selenium; Trace Elements | 2015 |
Learning from history in micronutrient research.
Topics: Dietary Supplements; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Selenium; Trace Elements | 2015 |
Selenitetriglycerides-Redox-active agents.
Topics: Aged; Animals; Antineoplastic Agents; Cysteine; Cystine; Extracellular Space; Humans; Liver; Male; Mice; Mice, Inbred NOD; Mice, SCID; Oxidation-Reduction; Oxidative Stress; Prostatic Neoplasms; Selenium; Selenium Compounds; Sulfhydryl Compounds; Tissue Distribution; Triglycerides | 2015 |
JNCI and cancer prevention.
Topics: Biomedical Research; Breast Neoplasms; Chemoprevention; Female; Food; Humans; Male; National Cancer Institute (U.S.); Neoplasms; Primary Prevention; Prostatic Neoplasms; Public Health; Secondary Prevention; Selenium; Smoking Cessation; United States; Vitamin E | 2015 |
Selenium, nickel, and calcium levels in cancerous and non-cancerous prostate tissue samples and their relation with some parameters.
Topics: Adenocarcinoma; Aged; Calcium; Humans; Limit of Detection; Male; Middle Aged; Nickel; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Factors; Selenium; Seminal Vesicles | 2015 |
Prostate cancer: Selenium, lycopene and GTC-a case of 'chemopromotion'.
Topics: Carotenoids; Humans; Male; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium | 2015 |
Prenatal exposure to soy and selenium reduces prostate cancer risk factors in TRAMP mice more than exposure beginning at six weeks.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Dietary Supplements; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Transgenic; Pregnancy; Prenatal Exposure Delayed Effects; Prostatic Neoplasms; Protective Factors; Selenium; Soy Foods | 2016 |
Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Topics: Case-Control Studies; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Glutathione Peroxidase; Humans; Male; Middle Aged; Neoplasm Invasiveness; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Selenium; Selenium-Binding Proteins; Selenoproteins; Thioredoxin Reductase 1; Thioredoxin Reductase 2 | 2016 |
Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dietary Supplements; Early Detection of Cancer; Finland; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Puberty; Risk Assessment; Risk Factors; Selenium; Ubiquinone; Vitamin D; Vitamin E; Vitamins; Zinc | 2016 |
Selenium status and risk of prostate cancer in a Danish population.
Topics: Biomarkers; Deficiency Diseases; Denmark; Disease Progression; Humans; Male; Middle Aged; Nutritional Status; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Selenoprotein P; Severity of Illness Index; Trace Elements | 2016 |
Is There a Future for Chemoprevention of Prostate Cancer?
Topics: Anticarcinogenic Agents; Biomarkers; Chemoprevention; Clinical Trials, Phase II as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2016 |
Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.
Topics: Aged; Case-Control Studies; Humans; Male; Middle Aged; Nails; Prospective Studies; Prostatic Neoplasms; Protective Factors; Risk Assessment; Selenium; Toes | 2016 |
Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Synergism; Humans; Male; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Selenium; Up-Regulation; Vitamin E | 2008 |
Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blood Chemical Analysis; Diagnosis, Differential; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium; Spectrophotometry, Atomic | 2009 |
Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells.
Topics: Apoptosis; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Humans; Isoenzymes; Male; Organoselenium Compounds; Oxygen; Prostatic Neoplasms; Protein Kinase C; RNA, Small Interfering; Selenium | 2008 |
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Topics: Aged; alpha-Tocopherol; Antioxidants; Case-Control Studies; Cohort Studies; Europe; gamma-Tocopherol; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2008 |
Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause.
Topics: Antioxidants; Ascorbic Acid; Dietary Supplements; Humans; Male; Neoplasms; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Topics: Adenocarcinoma; Alleles; Case-Control Studies; Genetic Predisposition to Disease; Humans; Hydrogen Peroxide; Male; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Selenium; Selenoprotein P; Superoxide Dismutase; Sweden | 2008 |
Vitamin supplements and cancer prevention: where do randomized controlled trials stand?
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Colorectal Neoplasms; Confounding Factors, Epidemiologic; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Lung Neoplasms; Male; Neoplasms; Primary Prevention; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; United States; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Plasma selenium concentration and prostate cancer risk: effects are dependent on the level of exposure.
Topics: Europe; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium | 2009 |
Selenium for prostate cancer prevention.
Topics: Antioxidants; Ascorbic Acid; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Lifestyle factors for longer life.
Topics: Antioxidants; Ascorbic Acid; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Plasma selenium concentration and prostate cancer risk.
Topics: Humans; Male; Prevalence; Prostatic Neoplasms; Risk Factors; Selenium | 2009 |
Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort.
Topics: Adult; Aged; Antioxidants; Biomarkers; Carotenoids; Cohort Studies; Demography; F2-Isoprostanes; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Tocopherols; Vitamin A | 2009 |
Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.
Topics: Androgens; Apoptosis; Caspase 3; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Enzyme Activation; Epithelial Cells; Humans; Male; Poly(ADP-ribose) Polymerases; Prostatic Hyperplasia; Prostatic Neoplasms; RNA, Messenger; Selenium; Sodium Selenite; Thioredoxin-Disulfide Reductase | 2009 |
In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.
Topics: Animals; Antigens, Differentiation; Antioxidants; Apoptosis; Biomarkers, Tumor; Carcinoma; Cell Cycle Proteins; Cell Proliferation; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Models, Biological; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Selenium; Transcription Factor CHOP; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology.
Topics: Animals; Black or African American; Chemoprevention; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Selenoproteins; Treatment Outcome; Vitamin E | 2009 |
On call. I have been taking selenium in the hope that it would prevent me from getting prostate cancer. But I heard on the radio that the National Cancer Institute is advising men to stop taking selenium. Should I stop it?
Topics: Antioxidants; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Prostate cancer: neither vitamin E nor selenium prevents prostate cancer.
Topics: Dietary Supplements; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2009 |
Antioxidants: SELECTed out?
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; Clinical Trials as Topic; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium | 2009 |
[Comparative study on selenium and amino acids content in leaves of planted and wild Scutellaria baicalensis].
Topics: Amino Acids; Humans; Male; Phytotherapy; Plant Extracts; Plant Leaves; Plant Stems; Prostatic Neoplasms; Scutellaria baicalensis; Selenium; Tea | 2009 |
Selenoprotein W modulates control of cell cycle entry.
Topics: Base Sequence; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Primers; Female; Humans; Male; Models, Biological; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; RNA Interference; RNA, Messenger; RNA, Small Interfering; Selenium; Selenoprotein W; Sodium Selenite | 2009 |
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.
Topics: Animals; Apoptosis; Blotting, Western; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Transgenic; Micronutrients; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Selenium and vitamin E supplementation for cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Selenomethionine; Vitamin E | 2009 |
Selenium and vitamin E supplementation for cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Selenomethionine; Vitamin E | 2009 |
Antioxidant supplementation and cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Survival Analysis; Vitamin E | 2009 |
RE: Lessons from the selenium and vitamin E cancer prevention trial (SELECT).
Topics: Antioxidants; Clinical Trials as Topic; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
Topics: Age Distribution; Aged; Aged, 80 and over; Cross-Sectional Studies; Dietary Supplements; Genetic Variation; Humans; Incidence; Male; Middle Aged; Primary Prevention; Prognosis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Vitamin E | 2009 |
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy, Needle; Cohort Studies; Confidence Intervals; Cross-Sectional Studies; Gene Expression Regulation, Neoplastic; Genotype; Humans; Immunohistochemistry; Linear Models; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Probability; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Selenium; Superoxide Dismutase; Survival Analysis | 2009 |
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.
Topics: Cell Line, Tumor; Chromatography, High Pressure Liquid; Histone Deacetylase Inhibitors; Histones; Humans; Inhibitory Concentration 50; Keto Acids; L-Amino Acid Oxidase; Lyases; Male; Mass Spectrometry; Methionine; Prostatic Neoplasms; Protein Processing, Post-Translational; Selenium; Transaminases | 2009 |
Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue.
Topics: Aged; Biopsy; Glutathione Peroxidase; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Selenium; Spectrophotometry, Atomic; Statistics, Nonparametric | 2009 |
Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Calcium; Copper; Down-Regulation; Homeostasis; Humans; Magnesium; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Up-Regulation; Zinc | 2009 |
Re: Selenium and vitamin E: interesting biology and dashed hope.
Topics: Animals; Anticarcinogenic Agents; Humans; Male; Meta-Analysis as Topic; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Vitamin E | 2009 |
Selenium supplementation loses favor.
Topics: Diabetes Mellitus; Dietary Supplements; Humans; Hypercholesterolemia; Male; Prostatic Neoplasms; Risk Factors; Selenium | 2009 |
Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Magnetic Resonance Spectroscopy; Male; Organoselenium Compounds; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium; Sulfonamides | 2010 |
Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells.
Topics: Anticarcinogenic Agents; Antioxidants; Apoptosis; Blotting, Western; Brassica; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Flow Cytometry; Food, Fortified; Humans; Intracellular Signaling Peptides and Proteins; Male; Plant Extracts; Plant Stems; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Selenium; Signal Transduction; TOR Serine-Threonine Kinases | 2009 |
Selenium and prostate cancer.
Topics: Humans; Male; Prostatic Neoplasms; Selenium | 2010 |
Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Antioxidants; Black or African American; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Patient Selection; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Support as Topic; Selenium; United States; Vitamin E | 2010 |
Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cadmium; Humans; Kidney; Liver; Male; Middle Aged; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2010 |
Correspondence (letter to the editor): Lucid scientific analysis.
Topics: Antioxidants; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Reactive Oxygen Species; Selenium; Vitamins; Wine | 2010 |
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Topics: Case-Control Studies; Drug Resistance, Neoplasm; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium; Selenoproteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
[Selenium in complementary oncology. A critical comments on the SELECT trial].
Topics: Antioxidants; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Selenium Compounds; Vitamin E | 2010 |
Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.
Topics: Androgens; Animals; Carotenoids; Cell Proliferation; Cysteine; Lycopene; Male; Neoplasm Transplantation; Organoselenium Compounds; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Tumor Burden; Vitamin E | 2010 |
Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antioxidants; Biomarkers, Tumor; Cross-Sectional Studies; Genotype; Glutathione Peroxidase; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Superoxide Dismutase; Transcription Factors | 2011 |
Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Blood Platelets; Carotenoids; Dietary Supplements; Disease Progression; Immunohistochemistry; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neovascularization, Pathologic; Platelet Adhesiveness; Platelet Factor 4; Prostatic Neoplasms; Proteomics; Selenium; Time Factors; Tumor Burden; Up-Regulation; Vitamin E | 2010 |
[Relation between selenium plasma levels and different prostatic pathologies].
Topics: Cross-Sectional Studies; Humans; Male; Middle Aged; Prostatic Diseases; Prostatic Neoplasms; Selenium | 2010 |
Genistein-selenium combination induces growth arrest in prostate cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Genistein; Growth Inhibitors; Humans; Male; Matrix Metalloproteinase 2; Prostatic Neoplasms; Selenium | 2010 |
Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men.
Topics: Adult; Biomarkers; Black or African American; Blood Proteins; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Proteomics; Selenium; Treatment Outcome; White People; Yeast, Dried | 2010 |
A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.
Topics: Apoptosis; Calcium; Cell Line, Tumor; Drug Resistance, Neoplasm; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Selenium; Signal Transduction | 2010 |
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.
Topics: Antioxidants; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2010 |
Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
Topics: Adult; Case-Control Studies; Europe; Genetic Predisposition to Disease; Genotype; Glutathione Peroxidase; Humans; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Selenium; Selenoproteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Prostate cancer outcome and tissue levels of metal ions.
Topics: Cadmium; Case-Control Studies; Environmental Exposure; Follow-Up Studies; Humans; Ions; Iron; Male; Prostate; Prostatic Neoplasms; Selenium; Treatment Outcome; Zinc | 2011 |
Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Down-Regulation; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Neoplasms; Male; Neoplasm Metastasis; Organoselenium Compounds; Procollagen-Proline Dioxygenase; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium; Vascular Endothelial Growth Factor A | 2012 |
The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Light; Male; Nanoparticles; Phosphorylation; Photoelectron Spectroscopy; Prostatic Neoplasms; Protein Biosynthesis; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Receptors, Androgen; Scattering, Radiation; Selenium; Transcription, Genetic; Ubiquitination | 2011 |
Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Topics: Aged; Biomarkers, Tumor; Cadmium; Glutathione; Humans; Lead; Male; Malondialdehyde; Middle Aged; Neoplasm Grading; Oxidative Stress; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Carbonylation; Selenium | 2012 |
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up.
Topics: Aged; DNA Glycosylases; Follow-Up Studies; Genotype; Humans; Incidence; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Assessment; Selenium; Smoking; Superoxide Dismutase | 2011 |
Effect of dietary selenium and cancer cell xenograft on peripheral T and B lymphocytes in adult nude mice.
Topics: Animals; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dietary Supplements; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Size; Prostatic Neoplasms; Selenium; Spleen; T-Lymphocytes; Time Factors; Transplantation, Heterologous; Tumor Burden | 2012 |
The effect of selenium enrichment on baker's yeast proteome.
Topics: Antibodies, Neoplasm; Dietary Supplements; Gene Expression Regulation, Fungal; Humans; Incidence; Male; Prostatic Neoplasms; Proteome; Proteomics; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Selenium; Software | 2012 |
Vitamin E and prostate cancer: research focus turns to biologic mechanisms.
Topics: Antioxidants; Humans; Male; Nutrition Surveys; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Smoking; United States; Vitamin E | 2011 |
Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice.
Topics: Aging; Animals; Anticarcinogenic Agents; Cell Line, Tumor; Dietary Supplements; Humans; Male; Mice; Mice, Nude; Necrosis; Prostatic Neoplasms; Random Allocation; Selenic Acid; Selenium; Selenium Compounds; Time Factors; Tumor Burden; Weight Loss; Xenograft Model Antitumor Assays | 2012 |
Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?
Topics: Antioxidants; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Follow-Up Studies; Heart; Humans; Male; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Skin Neoplasms; Vitamin E | 2012 |
Prostate cancer risk and vitamin E.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
Prostate cancer risk and vitamin E.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
[Demand for and clinical practice of complementary selenium therapy in prostate cancer patients].
Topics: Aged; Complementary Therapies; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium | 2012 |
A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom.
Topics: Calcium, Dietary; Case-Control Studies; Cross-Sectional Studies; Diet; Dietary Proteins; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium; United Kingdom | 2012 |
Selenium and prostate cancer: the puzzle isn't finished yet.
Topics: Diet; Humans; Male; Prostatic Neoplasms; Selenium | 2012 |
Vitamin E and prostate cancer.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
Prevalence and predictors of selenium and vitamin E supplementation in a urology population.
Topics: Adult; Antioxidants; Dietary Supplements; Educational Status; Health Literacy; Humans; Male; Micronutrients; Multivariate Analysis; Prostatic Neoplasms; Selenium; Surveys and Questionnaires; Urology; Vitamin E | 2013 |
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Topics: Adult; Aged; Case-Control Studies; Cohort Studies; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Prostatic Neoplasms; Risk Factors; RNA, Messenger; Selenium; Selenoprotein P; Survival Analysis | 2013 |
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Topics: Case-Control Studies; Disease Progression; Genotype; Glutathione Peroxidase; Humans; Male; Models, Genetic; Models, Statistical; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Selenium; Selenoprotein P; Selenoproteins; Thioredoxin-Disulfide Reductase | 2012 |
Variation in selenoenzyme genes and prostate cancer risk and survival.
Topics: Adult; Aged; Case-Control Studies; Genetic Predisposition to Disease; Genetic Variation; Glutathione Peroxidase; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Selenium | 2013 |
Association between trace element and heavy metal levels in hair and nail with prostate cancer.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Copper; Hair; Humans; Iron; Male; Manganese; Middle Aged; Nails; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; Zinc | 2012 |
Prostate disease risk factors among a New Zealand cohort.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Catalase; Cohort Studies; Genotype; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Male; Middle Aged; New Zealand; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Selenium; Selenoproteins; Smoking | 2012 |
Re: Plasma selenium level before diagnosis and the risk of prostate cancer development.
Topics: Age Factors; Aged; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium | 2002 |
SELECT (opportunity for prostate cancer prevention).
Topics: Clinical Trials as Topic; Diet; Hawaii; Humans; Male; Middle Aged; Primary Prevention; Prostatic Neoplasms; Selenium; Vitamin E | 2002 |
Selenium and Vitamin E Cancer Prevention Trial--this one's for us.
Topics: Antioxidants; Black or African American; Humans; Male; Prostatic Neoplasms; Research Design; Selenium; Vitamin E | 2002 |
Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Death; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA Fragmentation; G1 Phase; Humans; Immunoblotting; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Kinases; S Phase; Selenium; Sodium Selenite; Superoxides; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2002 |
Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.
Topics: Active Transport, Cell Nucleus; Adenoviridae; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Nucleus; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; I-kappa B Kinase; Luciferases; Male; NF-kappa B; Organoselenium Compounds; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Binding; Protein Serine-Threonine Kinases; Selenium; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2002 |
Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
Topics: Adult; Alleles; Genes, p53; Genotype; Glutathione Peroxidase; Humans; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Selenium; Trinucleotide Repeats | 2002 |
Selenomethionine does not affect PSA secretion independent of its effect on LNCaP cell growth.
Topics: Agar; Cell Division; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Selenomethionine; Stem Cells; Tumor Cells, Cultured | 2003 |
The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements.
Topics: Aspirin; Dietary Supplements; Disease Progression; Humans; Male; Prostatic Neoplasms; Selenium; Vitamins | 2003 |
Supplements and the prostate: widespread use, little evidence.
Topics: Adult; Aged; Antioxidants; Clinical Trials as Topic; Dietary Supplements; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Sensitivity and Specificity; Vitamin E; Vitamins | 2003 |
The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carotenoids; Cell Count; Dose-Response Relationship, Drug; Humans; Lycopene; Male; Malondialdehyde; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Selenium; Sensitivity and Specificity; Tumor Cells, Cultured; Vitamin E | 2003 |
Frequent use of complementary medicine by prostate cancer patients.
Topics: Aged; Aged, 80 and over; Austria; Combined Modality Therapy; Complementary Therapies; Dietary Fats; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Selenium; Surveys and Questionnaires; Vitamin E | 2003 |
By the way, doctor. I've had prostate cancer and am taking selenium in hopes of keeping it under control. Will it affect the absorption of vitamins?
Topics: Absorption; Animals; Antioxidants; Drug Interactions; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Selenium; Vitamins | 2003 |
[Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer].
Topics: Adenocarcinoma; Cadmium; Copper; Humans; Male; Prostatic Neoplasms; Selenium; Zinc | 2003 |
Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Cohort Studies; Cryptoxanthins; Follow-Up Studies; Humans; Lycopene; Male; Middle Aged; Nails; Netherlands; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium; Smoking; Surveys and Questionnaires; Vitamin E; Xanthophylls | 2003 |
Inuit are protected against prostate cancer.
Topics: Adult; Aged; Diet; Fatty Acids, Omega-3; Greenland; Humans; Incidence; Inuit; Male; Middle Aged; Prevalence; Prostatic Neoplasms; Retrospective Studies; Selenium | 2003 |
Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Humans; Isoenzymes; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2003 |
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Complementary Therapies; Health Surveys; Humans; Male; Middle Aged; Ontario; Phytotherapy; Plant Extracts; Prevalence; Prostatic Neoplasms; Random Allocation; Sampling Studies; Selenium; Self-Help Groups; Serenoa; Surveys and Questionnaires; Vitamin E | 2003 |
Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
Topics: Antioxidants; Cell Cycle; Cell Division; Chemoprevention; Drug Interactions; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Selenium; Tumor Cells, Cultured; Vitamin E | 2004 |
Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
Topics: Apoptosis; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Caspase Inhibitors; Caspases; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Male; Oligopeptides; Prostatic Neoplasms; Selenium | 2004 |
DNA stability and serum selenium levels in a high-risk group for prostate cancer.
Topics: Aged; Biomarkers, Tumor; Cohort Studies; Comet Assay; Diet; Dietary Supplements; DNA Damage; DNA Repair; Glutathione Peroxidase; Humans; Leukocytes; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium | 2004 |
Selenium and selenomethionine levels in prostate cancer patients.
Topics: Aged; Biomarkers, Tumor; Biopsy, Needle; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Humans; Male; Middle Aged; Prognosis; Prostatectomy; Prostatic Neoplasms; Reference Values; Sampling Studies; Selenium; Selenomethionine; Sensitivity and Specificity | 2004 |
A case--control study of selenium in nails and prostate cancer risk in British men.
Topics: Aged; Case-Control Studies; Dietary Supplements; Humans; Male; Middle Aged; Nails; Prostatic Neoplasms; Risk; Selenium; Smoking; United Kingdom; Vitamin E | 2004 |
B.E.A.R. GeneInfo: a tool for identifying gene-related biomedical publications through user modifiable queries.
Topics: Databases, Genetic; Genes, Neoplasm; Humans; Information Storage and Retrieval; Male; Prostatic Neoplasms; Publications; PubMed; Selenium; Software; Software Design; User-Computer Interface | 2004 |
A prospective study of plasma selenium levels and prostate cancer risk.
Topics: Adult; Aged; Anticarcinogenic Agents; Antioxidants; Case-Control Studies; Controlled Clinical Trials as Topic; Disease Progression; Humans; Male; Middle Aged; Odds Ratio; Patient Selection; Physicians; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Selenium; Severity of Illness Index | 2004 |
Selenium levels of patients with newly diagnosed prostate cancer compared with control group.
Topics: Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Humans; Male; Middle Aged; Nails; Prospective Studies; Prostatic Neoplasms; Regression Analysis; Selenium | 2004 |
Antioxidants block prostate cancer in lady transgenic mice.
Topics: Animals; Antigens, Viral, Tumor; Antioxidants; Carotenoids; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Diet; Female; Immunohistochemistry; Lycopene; Male; Mice; Mice, Transgenic; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Selenium; Testosterone; Tumor Suppressor Proteins; Vitamin E | 2004 |
Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Cell Line, Tumor; DNA, Neoplasm; Expressed Sequence Tags; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 3; Male; Neoplasm Proteins; Prostatic Neoplasms; Rats; Retinoid X Receptor alpha; RNA, Messenger; RNA, Neoplasm; Selenium; Selenomethionine; Species Specificity; Subtraction Technique | 2004 |
Intake of selected nutritional supplements by African-American men.
Topics: Adult; Black People; Complementary Therapies; Dietary Supplements; Humans; Male; Middle Aged; Plant Extracts; Prostatic Neoplasms; Selenium; Serenoa; United States; Vitamins | 2004 |
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Canada; Clinical Trials, Phase III as Topic; Humans; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Research Design; Selenium; United States; Vitamin E | 2005 |
Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte vi
Topics: Adult; Antioxidants; Biomarkers; Blood Chemical Analysis; Cell Survival; Endpoint Determination; Humans; Lymphocytes; Male; Middle Aged; Prostatic Neoplasms; Selenium; Specimen Handling; Time Factors; Vitamin E | 2005 |
Selenium/cadmium ratios in human prostates: indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cadmium; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2005 |
Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Genetic Predisposition to Disease; Humans; Lycopene; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Superoxide Dismutase | 2005 |
Selenium level in benign and cancerous prostate.
Topics: Aged; Diet; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium | 2005 |
Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Topics: Age Factors; Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; DNA Damage; Dogs; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Random Allocation; Selenium | 2005 |
Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia.
Topics: Aged; Erythrocytes; Glutathione Peroxidase; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium | 2005 |
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.
Topics: Biomarkers, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases; Male; Organoselenium Compounds; Prostatic Neoplasms; Receptors, Androgen; Selenium; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured | 2005 |
Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Caspases; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Flow Cytometry; G2 Phase; Humans; Immunoblotting; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; Male; Prostatic Neoplasms; Reactive Oxygen Species; Selenium; Sulfoxides; Thiocyanates; Tumor Cells, Cultured | 2005 |
Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity.
Topics: Androgen Receptor Antagonists; Antioxidants; Bromodeoxyuridine; DNA Replication; DNA, Neoplasm; Epithelial Cells; Humans; Male; Prostate; Prostatic Neoplasms; Quercetin; Receptors, Androgen; Selenium; Tumor Cells, Cultured | 2006 |
Neural network-based analysis of thiol proteomics data in identifying potential selenium targets.
Topics: Antineoplastic Agents; Biotin; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Ethylenediamines; Humans; Male; Neural Networks, Computer; Organoselenium Compounds; Oxidation-Reduction; Prostatic Neoplasms; Proteins; Proteome; Proteomics; Selenium; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfhydryl Compounds | 2006 |
Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Cobalt; Copper; Humans; Iron; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nickel; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin A; Vitamin E; Zinc | 2006 |
Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Antineoplastic Agents; Calcineurin; Calcium; Cell Membrane; Humans; Male; Organoselenium Compounds; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Selenium; Threonine | 2006 |
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cysteine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Selenium; Selenocysteine; Xenograft Model Antitumor Assays | 2006 |
Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Androgen; Selenium; Signal Transduction | 2006 |
Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups.
Topics: Adult; Aged; Cadmium; Environmental Monitoring; Environmental Pollutants; Epidemiological Monitoring; Ethnicity; Humans; Male; Middle Aged; New Zealand; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium; Zinc | 2005 |
Accidental death from acute selenium poisoning.
Topics: Acute Disease; Aged; Complementary Therapies; Fatal Outcome; Humans; Internet; Male; Prostatic Neoplasms; Selenium; Self Medication; Trace Elements | 2006 |
A permutation test for a weighted Kaplan-Meier estimator with application to the nutritional prevention of cancer trial.
Topics: Area Under Curve; Bias; Colorectal Neoplasms; Dietary Supplements; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasms; Proportional Hazards Models; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Treatment Failure; Treatment Outcome; Yeast, Dried | 2007 |
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells.
Topics: Humans; Hydrogen Peroxide; Male; Mercury; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Selenoproteins; Sodium Selenite; Tumor Cells, Cultured | 2007 |
Serum selenium and risk of prostate cancer-a nested case-control study.
Topics: Aged; Antioxidants; Case-Control Studies; Confidence Intervals; Humans; Male; Micronutrients; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; Smoking; Vitamin E; Vitamins | 2007 |
Selenium and prostate cancer.
Topics: Atherosclerosis; Colorectal Neoplasms; Dietary Supplements; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Selenium; Skin Neoplasms | 2007 |
Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antioxidants; Black or African American; Child; Female; Humans; Incidence; Male; Middle Aged; Nutrition Surveys; Prostatic Neoplasms; Selenium; Trace Elements; United States; White People | 2007 |
High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells.
Topics: Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; NF-kappa B; Polymerase Chain Reaction; Prostatic Neoplasms; RNA, Messenger; Selenium; Tumor Cells, Cultured | 2007 |
Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Topics: Aged; Cohort Studies; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; SEER Program; Selenium; Vitamin E; Vitamins | 2008 |
Selenium: maybe this mineral isn't such a gem after all.
Topics: Diabetes Mellitus; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium | 2007 |
Selenium and prostate cancer. Can it lower risk?
Topics: Humans; Male; Prostatic Neoplasms; Selenium | 2007 |
Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Organoselenium Compounds; Prostatic Neoplasms; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; RNA, Small Interfering; Selenium; Transcription, Genetic; Up-Regulation | 2008 |
Serum selenium level and prostate cancer: a case-control study.
Topics: Aged; Biomarkers; Body Mass Index; Case-Control Studies; Confidence Intervals; Humans; Iran; Male; Odds Ratio; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2008 |
Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Confidence Intervals; Erythrocytes; Glutathione Peroxidase; Humans; Male; Middle Aged; Odds Ratio; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium; Sweden | 1995 |
Selenium, vitamin E, and prostate cancer--ready for prime time?
Topics: Black or African American; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 1998 |
Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer.
Topics: Adult; Aged; Case-Control Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nails; Odds Ratio; Prostatic Neoplasms; Risk; Selenium; Surveys and Questionnaires; Toes | 1998 |
Selenium and risk of prostate cancer.
Topics: Dietary Supplements; Double-Blind Method; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium | 1998 |
Prostate cancer screening.
Topics: Anticarcinogenic Agents; Antioxidants; beta Carotene; Carotenoids; Diet; Humans; Lycopene; Male; Mass Screening; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium; Solanum lycopersicum; Vitamin E | 1999 |
The dietary antioxidant network and prostate carcinoma.
Topics: Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Clinical Trials as Topic; Diet; Humans; Lycopene; Male; Phytotherapy; Prostatic Neoplasms; Risk; Selenium; Smoking; Solanum lycopersicum; Vitamin E | 1999 |
A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Humans; Incidence; Likelihood Functions; Linear Models; Longitudinal Studies; Male; Middle Aged; Models, Biological; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Regression Analysis; Selenium | 2000 |
Serum selenium and subsequent risk of prostate cancer.
Topics: Aged; Case-Control Studies; Hawaii; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2000 |
A case-control study of toenail selenium and cancer of the breast, colon, and prostate.
Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Child; Child, Preschool; Colonic Neoplasms; Diet; Female; Humans; Infant; Logistic Models; Male; Middle Aged; Nails; Neutron Activation Analysis; Odds Ratio; Prostatic Neoplasms; Selenium; Smoking; Toes | 2000 |
Chemoprevention: an important treatment option for prostate cancer.
Topics: Aged; Antioxidants; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E | 2000 |
Selenium effects on prostate cell growth.
Topics: Apoptosis; Cell Cycle; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Selenium; Sodium Selenite; Tumor Cells, Cultured | 2000 |
Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
Topics: Aged; Case-Control Studies; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk; Risk Factors; Selenium; Vitamin E | 2000 |
Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Antioxidants; Carotenoids; Dietary Fats; Forecasting; Humans; Lycopene; Male; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Selenium; Vitamin E | 2001 |
New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents.
Topics: Anticarcinogenic Agents; Antioxidants; Biomarkers, Tumor; DNA, Complementary; Gene Expression; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Prostatic Neoplasms; Selenium; Specimen Handling | 2001 |
Enrollment begins for largest-ever prostate cancer prevention trial.
Topics: Canada; Clinical Trials as Topic; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms; Puerto Rico; Selenium; United States; Vitamin E | 2001 |
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
Topics: Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2001 |
Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
Topics: Age Distribution; Aged; Analysis of Variance; Biomarkers, Tumor; Case-Control Studies; Cohort Studies; Female; Humans; Incidence; Logistic Models; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Probability; Prostatic Neoplasms; Reference Values; Risk Factors; Selenium; Sensitivity and Specificity; Sex Distribution; Smoking | 2001 |
Prostate cancer prevention trial launched.
Topics: Dietary Supplements; Humans; Male; National Institutes of Health (U.S.); Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E | 2001 |
Plasma selenium level before diagnosis and the risk of prostate cancer development.
Topics: Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium | 2001 |
Discovering subpopulation structure with latent class mixed models.
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Back Pain; Diagnosis-Related Groups; Eye Movements; Humans; Insurance, Health, Reimbursement; Linear Models; Longitudinal Studies; Male; Models, Biological; Practice Patterns, Physicians'; Prostate-Specific Antigen; Prostatic Neoplasms; Schizophrenia; Selenium; Survival Analysis | 2002 |
Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines.
Topics: Biomarkers, Tumor; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; G1 Phase; Growth Inhibitors; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Selenium; Transfection; Tumor Suppressor Proteins | 2002 |
Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.
Topics: Androgen Receptor Antagonists; Animals; Antioxidants; Cell Division; Chlorocebus aethiops; COS Cells; Dimerization; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Biosynthesis; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Selenium; Tocopherols; Transcription Factors; Tumor Cells, Cultured; Vitamin E | 2002 |
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia; Hypolipidemic Agents; Intestinal Neoplasms; Liver Neoplasms; Male; Pancreatic Neoplasms; Phenylpropionates; Prostatic Neoplasms; Rats; Rats, Inbred F344; Resorcinols; Selenium; Testicular Neoplasms; Vitamin E | 1991 |
Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.
Topics: Aged; Cadmium; Case-Control Studies; Diet; Dietary Fats; Energy Intake; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenium; Utah; Vitamins; Zinc | 1991 |
[Serum selenium levels of patients with adenoma and carcinoma of the prostate gland].
Topics: Diagnosis, Differential; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Selenium | 1987 |
Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology.
Topics: Cadmium; Cell Fractionation; Epithelial Cells; Epithelium; Humans; Hyperplasia; Male; Prostate; Prostatic Neoplasms; Reference Values; Selenium; Tissue Distribution; Zinc | 1987 |
Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro.
Topics: Animals; Cell Division; Cell Line; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; In Vitro Techniques; Male; Mammary Neoplasms, Experimental; Mice; Prostatic Neoplasms; Selenium | 1985 |